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ABSTRACT
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the
western culture and worldwide. Its morbidity has been raising and it has become a burden
on the public health. NAFLD is associated with other metabolic diseases such as Diabetic
Mellitus and hypertension. NAFLD is a wide spectrum of symptoms, from an
accumulation of fat in the liver (cirrhosis) to production of scar tissue (Fibrosis). The
liver along with other distal organs such as the kidney and cardiovascular system can be
damaged as ectopic manifestations of NAFLD. Contamination of drinking water with
Cyanobacterium

toxin

(Microcystin)

and

water

disinfection

byproduct

like

trihalomethane (like Bromodichloromethane) play a critical role in progressing NAFLD.
Here, I have examined the molecular mechanism of BDCM and microcystin in induce
glomerular toxicity and renal inflammation when NAFLD was present. I found that
BDCM can induce glomerular inflammation when NAFLD is present. BDCM caused
renal immunotoxicity and impacted glomerular function through high mobility group
box-1 (HMGB1) and mesangial cell activation. Mesangial cell activation can be caused
by increasing leptin level after BDCM exposure. High leptin level upregulated mesangial
cell NOX2 and increased miR-21 expression which in turn released TGF-b and caused
tubular inflammation. In-vitro, mesangial cells proliferated and increased alpha smooth
muscle actin (αSMA) expression after they were treated with leptin. Leptin caused
mesangial cell NOX2 subunits Gp91 and P47 phox to colocalize via JAK/ STAT
pathway dependence which in turn increased peroxynitrite releasing, miR21 activation,
v

and TGFb expression. Furthermore, mesangial cells NOX2 activation by leptin exposure
attenuated after Apocynin treatment. Comparing with tubular cells kept on cell culture
media only, tubular cells incubated with leptin- treated mesangial cell supernatant
showed increases in inflammatory marker expressions like IL-1β, TNF-α, and interferonγ. Microcystin is another example of a toxin that could increase the severity of
glomerulonephritis caused by NAFLD. Here I found that microcystin can accelerate
NAFLD toxicity in the kidney. High expression of αSMA found in NAFLD mice treated
with microcystin compared with NAFLD mice alone and mice treated with microcystin
but did not have NAFLD. Renal tissue surrounding the glomeruli had increased NOX2
activation as shown by increased colocalization of NOX2 subunits, GP91and P47 Phox.
Mice lacking miR21 gene and mesangial cell line treated with miR21 inhibitor shown
significant decreased in mesangial cell activations and renal immunotoxicity. Thus,
microcystin exposure increased the severity of NAFLD caused glomerulonephritis via the
NOX2- miR21 axis.
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CHAPTER 1
INTRODUCTION
Nonalcoholic liver fatty disease (NAFLD) is now becoming the most common chronicliver
disease worldwide and it occurs in people who do not consume a high amount of alcohol.
NAFLD is prevalent in about 30% of the general western countries population and around
4% of the world population (1). Moreover, the number of NAFLD patients is growing
rapidly and the disease is becoming a public health encumbrance (2). NAFLD is a wide
spectrum with a progression of stages beginning with the accumulation of excessive fat in
hepatic cells, steatohepatitis, and cirrhosis, as well as sometimes including hepatocellular
carcinoma (3). Nonalcoholic steatohepatitis (NASH) is a progressive stage of NAFLD. It
is prevalent in 5% of the general NAFLD population and is the third most common liver
disease in the United States (4). NASH is necroinflammation histological condition in
hepatic cells caused by liver injury and inflammation after fat accumulation (5). Cirrhosis
is irreversible, and the final phase of NAFLD (6). Instead of alcoholic liver fatty disease,
which is caused by alcohol consumption, different risk factors can cause NAFLD. Some
primary risk factors for NAFLD are Diabetes Mellitus type two, hypertension, obesity, and
metabolic syndrome, while uncommon risk factors for NAFLD include disorders of lipid
metabolism, hepatitis infection type C, lipodystrophy, and some medications such as
corticosteroids and tamoxifen (3,7). Obesity is prevalent in 32% of adults and there is a
correlation between the prevalence of obesity and NAFLD (8,9). Although NAFLD affects
1

both obese and non-obese individuals, overweight and obese patients with NAFLD are four
times more than normal weight patients with NAFLD (10).
Obesity is a condition where the subjects have a body mass index (BMI) more
than 30. This excessive amount considers adipose tissue because of triglyceride
accumulation (11). In addition to work as a storage to the energy, adipose tissue canrelease
different cytokines, hormones, and other molecules, which together is called Adipokines
(12). Accumulation of fat causes adipocytes hypertrophy results in adipocytes damage and
the release of pro inflammatory cytokines. Adipocytes damage in visceral adipose tissue
lead to fibrosis, which in result leads to deposit fat in other organs, such as the liver and
muscles (13,14). The number of NAFLD patients and NAFLD severity correlates with
metabolic syndrome severity and progression (15). Thus, many studies considered NAFLD
to be a hepatic manifestation of metabolic syndrome with a risk factor that involves insulin
resistance development, which itself is considered a core feature of metabolic syndrome
(16). Different cohort studies found that patients with type 2 diabetes have an increased a
risk of NAFLD, and patients who suffer from NAFLD will have an increased chance of
developing type 2 diabetes (17, 18). Regarding which disease is developing first, NAFLD
and type 2 diabetes can occur due to exists and progresses of another disease. This
correlation may be due to the insulin molecule. In NAFLD condition, fat accumulates in
the liver results in high amount of insulin becoming necessary to fuel the body and that
causes type 2 diabetes to progress. Meanwhile, in type 2 diabetes, there is not enough
insulin to metabolize liver fat, which causes the development of NAFDL from steatosis to
NASH (17,19,20,21).
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Since both NAFLD and NAFLD progression link to other disorders, such as
metabolic syndrome and type 2 diabetes, NAFLD damage is not restricted to the liver, it
can be an extrahepatic problem. Cardiovascular disease and ecological diseases are the
main reason for death in NAFLD patients (22). Although the mechanical link between
NAFLD and cardiovascular disease is unclear, insulin resistance is widely considered the
most possible link between NAFLD and cardiovascular disease (23). NAFLD patients,
especially patients in the NASH stage, have shown endothelium dysfunction, which is a
hallmark of cardiovascular disease (24). In addition, patients proven to NAFLD also likely
have hyperlipidemia, increased low-density lipoprotein cholesterol (LDL) level, and
decreased high-density lipoprotein cholesterol level (HDL) (24). Type 2 diabetes is
associated with NAFLD and increases the risk of NASH. Furthermore, patients with type
2 diabetes and diagnosed with NAFLD are more susceptible to have chronic kidney disease
compared to patients without NAFLD (25,26,27). Prevalence of chronic kidney disease is
twice likely in patients with NAFLD compared to patients without NAFLD. Although
mechanistically, there are different theories of how NAFLD can link with kidney diseases,
like chronic kidney disease (CKD), fully understood of the mechanism does not yet exist.
One pathophysiological factor is that NAFLD and NASH cause increase releasing
biomarkers and proinflammatory cytokines, like TNFα, TGFβ, IL-6 from hepatocytes and
Kupffer cells. In turn, these biomarkers can circulate and promote chronic kidney disease
(28). Another pathway which can trigger kidney in the presence of NAFLD that NAFLD
leads to insulin resistance in the liver and then in the whole body, which in consequence
causes CRD (29). Decreasing adiponectin level via the progression of NAFLD can impact
the energy sensor 5'-AMP activated protein kinase (AMPK) pathway, which is important
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to Podocytes function, and results in the end stage renal disease ESRD (30). On another
hand, Georgescu EF showed that renin angiotensin system involved in insulin resistance,
resulting in promoting liver fibrogensis (31,32).
Since chlorination disinfection method has been added to the drinking water for a
long-time word wild, disinfection by products are found in the water source. (33). Although
disinfection water by chlorine is an important way to protect humans from microorganisms,
there is a link between disinfection by products (DBP) and organic toxicity, which results
in carcinogenic effect and disfunction in some organs, such as reproductive system and
liver (34, 35). Trihalomethanes (THMs), chloroform, bromoform, bromodichloromethane
(BDCM), and dibromochloromethane (DBCM), is a DBP existed when chlorine is used in
water to disinfect water from microorganisms. These THMs components are considered
the most abundant DBPs studied in epidemiological studies due to its public health
problems. BDCM impacts liver functions and develops NAFLD condition to NASH when
used as a second hit (35). Different studies found BDCM metabolized inside the liver
though xenobiotic metabolism enzyme (cytochrome P450), especially CYP2E1 (36).
Admission of BDCM can increase oxidative stress and release free radicals. Experimental
studies found that obese mice exposed to BDCM can cause NASH (37). Patients with
CYP2E1 polymorphisms are more susceptible to have NASH caused by environmental
factors since BDCM metabolize primarily by CYP2E1(38). Although THMs been
highlighted in multiple recent studies, different molecules impacted by exposure to THMs
are present. Recently, an experimental study from our lab found that Purinergic receptor
X7 (P2X7) can modulate NASH progression in obese mice after BDCM exposure (37,39).
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Cyanobacteria, is a common bacterium, present in fresh water over the entire globe,
and can grow and produce blooms under a specific environment like eutrophic water.
Cyanobacteria produce secondary metabolites as toxins which can harm other organs when
they grow excessively and cause accumulation of toxins (40). Cyanobacteria can produce
several toxins such as a microcystin, a potent toxin able to cause damage in multi organs
(41). The molecular weight of microcystin, heptapeptide structure, varies between 900 and
1,100 Daltons and its amino acid positions are different within the X and Y directions.
Despite that, many types of microcystin are identified, Microcystin-LR is a potent toxic
member of the microcystin family which is a commen in nature (42). Diffusion of
microcystin across the membrane is not possible due to its high molecular weight. Cells
take up microcystin by using transporters which help it cross the cell membrane (40).
Inherently, many transporters respond to endogenous and exogenous chemicals up taken
by cells including microcystin. These transporters include the organic anion transporting
polypeptides (Oatps), Nat-taurocholatecotransporting polypeptide (Ntcp), organic anion
transporters (Oats), and organic cation transporters (43-45). OATPs are very important
transporters in the liver, kidney, heart, and blood brain barrier (40). Microcystin-LR
interacts with serine/threonine protein phosphatases (protein phosphatases) such as PP1
and PP2a after cell exposed to microcystin (46). These enzymes are critical to cell
processing like cell apoptosis and proliferation (47). Plenty of molecules are controlled by
phosphorylation and dephosphorylation of protein phosphotase, for instance, NEK2,
MAPKs, and P53 (48-50). Reactive oxygen species (ROS) is meanly generated in
mitochondria to play a role in cellular processes from cell proliferation to apoptosis (51).
ROS generation is due to expenditure of glutathione, which is a necessary component to
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prevent cellular damage due to ROS (52). Microcystin-LR induces ROS and lipid
peroxidation, decreases cell viability, reduces mitochondrial membrane potential, and
finally induces cell apoptosis (52,53). Microcystin-LR leads to surge calcium in
mitochondria. Calcium surge leads to onset of mitochondrial permeability transition pore
(MPT). The consequence of MPT is changes in inner mitochondrial membrane
performance and generation of ROS (54-59). Nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase is a dominant source of ROS in the biologic system. There are several
isoforms of NADPH oxidase such as NOX1-5 and Doux1-2. NOX2 and NOX4 have been
implicated in ROS production in the kidney during pathologic conditions (60-61). NOX2
was first NADPH oxidase subunit discovered in Phagocytes, however, recently, several
studies found NOX2 expression in different types of cells like smooth muscle cells and
kidney mesangial cells (62).
MicroRNAs (miRNA) are small noncoded RNA about 22 nucleotides which can
control gene expression. In cytoplasm, miRNAs form mRNA silencing complexes which
regulate mRNA expression at transcriptions level (63). Among all miRNAs, miRNA21 is
highly expressed in different renal diseases such as Diabetic nephritis (DN) (64). Inhibition
of miRNA 21 in experimental models attenuated mesangial extra cellular matrix (65). In
this thesis, I inspect the mechanism pathway of different environmental toxins like BDCM
and microcystin in augmented NAFLD causing glomerulonephritis and kidney
inflammation
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CHAPTER 2
NKT CELL MODULATES NAFLD POTENTIATION OF
METABOLIC OXIDATIVE STRESS-INDUCED MESANGIAL CELL
ACTIVATION AND PROXIMAL TUBULAR TOXICITY

Firas Alhasson1, Diptadip Dattaroy1, Suvarthi Das1, Varun Chandrashekaran1 Ratanesh
Kumar Seth1, Rick G. Schnellmann2 and Saurabh Chatterjee1*. Alhasson F, Dattaroy D,
Das S, Chandrashekaran V, Seth RK, Schnellmann RG, et al. NKT cell modulates NAFLD
potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal
tubular toxicity. American journal of physiology Renal physiology. 2016;310:F85-F101.
Reprinted here with the permission of the publisher.
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1Environmental Health and Disease Laboratory, Department of Environmental Health
Sciences, Arnold School of Public Health, University of South Carolina, Columbia SC
29208.
Drug Discovery and Biomedical Sciences, Medical University of South Carolina,
Charleston, SC, United States.
Running Title: Liver CYP2E1 mediates kidney inflammation
Author for correspondence:
1*Dr. Saurabh Chatterjee, Ph.D. Environmental Health and Disease Laboratory,
Department of Environmental Health Sciences, University of South Carolina, Columbia
29208 USA. Email: schatt@mailbox.sc.edu; Tel: 803-777-8120; Fax: 803-777-3391
Key words: 4HNE, vα14, CD1d, CXCL16, HMGB1 TLR4.
GRANTS This work has been supported by National Institute of Environmental Health
Sciences Pathway to Independence Award 4-R00-ES-019875-02 (to S. Chatterjee)
Abstract:
Obesity and nonalcoholic fatty liver disease (NAFLD) are associated with the development
and progression of chronic kidney disease. We recently showed that NAFLD induces liverspecific cytochrome P-450 (CYP)2E1-mediated metabolic oxidative stress after
administration of the CYP2E1 substrate bromodichloromethane (BDCM) (Seth RK, Das
S, Kumar A, Chanda A, Kadiiska MB, Michelotti G, Manautou J, Diehl AM, Chatterjee S.
Toxicol Appl Pharmacol 274: 42–54, 2014; Seth RK, Kumar A, Das S, Kadiiska MB,
8

Michelotti G, Diehl AM, Chatterjee S. Toxicol Sci 134:291–303, 2013). The present study
examined the effects of CYP2E1-mediated oxidative stress in NAFLD leading to kidney
toxicity. Mice were fed a high-fat diet for 12 wk to induce NAFLD. NAFLD mice were
exposed to BDCM, a CYP2E1 substrate, for 4 wk. NAFLD + BDCM increased CYP2E1mediated lipid peroxidation in proximal tubular cells compared with mice with NAFLD
alone or BDCM-treated lean mice, thus ruling out the exclusive role of BDCM. Lipid
peroxidation increased IL-1β, TNF-α, and interferon-γ. In parallel, mesangial cell
activation was observed by increased α-smooth muscle actin and transforming growth
factor-β, which was blocked by the CYP2E1 inhibitor diallyl sulphide both in vivo and in
vitro. Mice lacking natural killer T cells (CD1d knockout mice) showed elevated (>4-fold)
proinflammatory mediator release, increased Toll-like receptor (TLR)4 and PDGF2
mRNA, and mesangial cell activation in the kidney. Finally, NAFLD CD1D knockout mice
treated with BDCM exhibited increased high mobility group box 1 and Fas ligand levels
and TUNEL-positive nuclei, indicating that higher cell death was attenuated in TLR4
knockout mice. Tubular cells showed increased cell death and cytokine release when
incubated with activated mesangial cells. In summary, an underlying condition of
progressive NAFLD causes renal immunotoxicity and aberrant glomerular function
possibly through high mobility group box 1-dependent TLR4 signaling and mesangial cell
activation, which, in turn, is modulated by intrinsic CD1D dependent natural killer T cell.
2.1 INTRODUCTION
over the last decade, there has been a phenomenal rise in obesity and metabolic syndrome.
The obesity phenotype is often associated with fatty liver (steatosis), leading to hepatic
inflammation, sinusoidal injury, and fibrosis (109). Fatty liver is also observed with liver-
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specific insulin and leptin resistance, leading to metabolic complications referred to as
nonalcoholic fatty liver disease (NAFLD) (78, 109). Advanced and progressive NAFLD
with inflammation with or without fibrosis and sinusoidal injury is termed “nonalcoholic
steatohepatitis” (NASH) (69). NAFLD/NASH is linked to extrahepatic comorbidities like
cardiovascular and renal complications (72, 108). For example, the cumulative evidence to
date suggests that individuals with NAFLD exhibit an increased risk of developing
cardiovascular disease, especially atherosclerosis and portal hypertension, type 2 diabetes,
and chronic kidney disease (CKD) (22). Advanced NAFLD/NASH was associated with a
higher prevalence (odd ration: 2.53, 95% confidence interval: 1.58–4.05) and incidence
(hazard ratio: 2.12, 95% confidence interval: 1.42–3.17) of CKD than simple steatosis
when assessed in cross-sectional and longitudinal studies with the severity of advanced
NAFLD/NASH being positively associated with CKD stages (90). The strong association
of advanced NAFLD/NASH with kidney disorders may lie in common factors underlying
the pathogenesis of NAFLD and CKD, including insulin resistance, oxidative stress,
activation of the reninangiotensin system, and secretion of inflammatory cytokines by the
steatotic and inflamed liver (70, 94, 103).
We have previously shown that oxidative stress is key for the progression of
NAFLD to NASH (110). Oxidative stress pathways like cytochrome P-450 (CYP)mediated
lipid peroxidation and NADPH oxidase can trigger the release of multiple proinflammatory
mediators that affect distal organs like the kidney (74, 100). It is equally important that the
intrinsic properties of proximal tubule cells act as immune responders and producers of a
wide range of immunological, ischemic, or toxic injury that may arise from the liver (91).
It is therefore not surprising that events in the proximal tubule are closely related to the
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pathogenesis of a vast array of kidney diseases (91). In parallel, proinflammatory mediators
in the circulation are filtered through the glomerulus, and those that are secreted locally
from the kidney epithelia can exert autocrine and paracrine effects on mesangial cells
(MCs), fibroblasts, vascular smooth muscle cells, and proximal tubular cells, which are
crucially involved in progressive renal diseases (68, 71). The kidney immunotoxicity and
inflammatory insult can be magnified by the activation of MCs, which are often found in
the vicinity of Bowman's capsule. Hyperplasia of MCs precedes or accompanies
progressive glomerular scarring, as seen in chronic glomerulonephritis and diabetic
glomerulosclerosis (101). MCs also generate soluble mediators that can, in a paracrine
fashion, attract and activate inflammatory cells (platelets, monocytes/macrophages, and
granulocytes). For example, IL-6, IL-8, monocyte chemoattractant protein-1, and
granulocyte-macrophage colony-stimulating factor exert autocrine effects on MCs, such as
by promoting MC proliferation (by PDGF, IL-1, and IL-6) or extracellular matrix
production [by transforming growth factor (TGF)β and IL-1] and might play a prominent
role in the initiation and progression of glomerular inflammation (101). MCs also resort to
proliferation upon activation by proinflammatory mediator-induced oxidative stress. This
is accompanied by the de novo expression of α-smooth muscle actin (α-SMA) and TGF-β
secretion (76, 87, 95, 97, 110). In parallel to studies regarding the role of MCs in chronic
kidney immunotoxicity, there is evidence of immunosuppressive roles of a class of T cells
including invariant and CD1D-dependent natural killer (NK)T cells (80). Invariant NKT
cells have been shown to inhibit the development of experimental crescentic
glomerulonephritis primarily via the involvement of dendritic cells and chemokine (C-XC motif) receptor (CXCR)6 and CXCR16 (96, 107). However, the cross talk between the
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regulatory and immunosuppressive NKT cells that have a prominent role in NAFLD has
never been explored for their role in NAFLD-induced kidney immunotoxicity.
Thus, it is justifiable to assume that a preexisting condition of advanced
NAFLD/NASH that has higher CYP2E1-mediated oxidative stress, release of damage
associated molecular patterns (DAMPS), higher insulin and leptin levels, and higher
inflammatory mediators in the circulation can cause oxidative stress distant to the liver,
especially in renal tubular cells. The presence of varied cell types within Bowman's capsule
and an activated proinflammatory phenotype of MCs raise the possibility of significant
cross talk between these cells and other proximal tubular cells via autocrine and paracrine
mechanisms, thus exacerbating renal injury in advanced NAFLD/NASH. In the present
study, we used a diet-induced NAFLD model where hepatotoxin bromodichloromethane
(BDCM) was used to generate CYP2E1-mediated oxidative stress and act as a “second hit”
to allow the liver to progress into advanced NAFLD/NASH with steatohepatitis and
fibrosis (35). Here, we show, using both in vivo and in vitro models, that advanced
NAFLD/NASH affected kidneys with a second hit in the form of increased lipid
peroxidation followed by MC activation and immunotoxicity in proximal tubular cells.
Interestingly, CD1D-dependent NKT cells were also present in advanced NAFLD/NASHaffected kidneys and played a crucial role in modulating the MC-induced immunotoxicity
in the proximal tubule.
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2.2 MATERIALS AND METHODS:
BDCM and corn oil were purchased from Sigma-Aldrich (St. Louis, MO). Diallylsulfide
(DAS) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti4hydroxynonenal (4-HNE), anti-IL1β, anti-TNF-α, anti-interferon (IFN)-γ, anti-high
mobility group box 1 (HMGB1), anti-chemokine (C-X-C motif) ligand (CXCL)16,
antiTGF-β, anti-Toll-like receptor (TLR)4, anti-CD4, anti-CD8, anti-F4/80, and antiαSMA primary antibodies were purchased from Abcam (Cambridge, MA). Speciesspecific biotinylated conjugated secondary antibody and streptavidin-horseradish
peroxidease were purchased from Vector Laboratories (Vectastain Elite ABC kit,
Burlingame, CA). Wild-type and gene-specific knockout (KO) mice were purchased from
The Jackson Laboratories (Bar Harbor, ME) and Taconic Farms (Hudson, NY). Animal
diets were purchased from Research Diets (New Brunswick, NJ). All other chemicals were
of analytic grade and were purchased from Sigma-Aldrich unless otherwise specified.
Paraffinized tissue sections on slides were done by the Instumentation Resource Facility of
the University of South Carolina School of Medicine and AML Laboratories (Baltimore,
MD).
Mouse models: All mice were housed with 1 mouse/cage at 23–24°C on a 12:12-h
lightdark cycle with libitum access to food and water. All animals had been treated in strict
accordance with the National Institutes of Health guidelines for the humane care and use
of laboratory animals and local Institutional Animal Care and Use Committee standards.
All experiments were approved by the institutional review board at the National Institute
of Environmental Health Sciences, Duke University, and University of South Carolina
Columbia, SC). Mice were given either 60% kcal high-fat diet or chow diet. After the
13

animal experiment was completed, mice of all study groups were euthanized for
kidneytissues and serum samples were taken for further experiments.
Mouse model of NAFLD: Male pathogen-free C57BL/6J background mice were used as
wild-type mice for the NAFLD model. These mice were fed a high-fat diet (60% kcal) from
6 wk until 16 wk. All experiments were conducted in the 16-wk age group. Age matched
lean control (LC) mice were fed a diet having 10% kcal fat. Animals were housed at 1
mouse/cage before any experimental use. Mice that contained the disrupted CD1D gene
(B6.129S6-Cd1d1/Cd1d2 < tm1Spb >/J), PFP/Rag2 dual gene deletion (B6.129S6Rag2tm1FwaPrf1tm1Clrk N12, Taconic Farms), and disrupted TLR4 gene (B6.B10ScNTlr4lps-del/JthJ) were fed a high-fat diet and treated identically to the NAFLD mouse
model.
Administration of BDCM and induction of kidney injury: High-fat diet-fed wild-type
mice (NAFLD model) and high-fat diet-fed gene KO mice (except for TLR4 gene KO
mice) at 16 wk were administered BDCM (1 mmol/kg, diluted in corn oil) intraperitoneally
for twice a week for 4 wk to assess the effects of chronic exposure to BDCM. High-fat
diet-fed TLR4 gene KO mice at 16 wk were administered with the same dose of BDCM
via an intraperitoneal injection for 1 wk. A set of high-fat diet-fed mice (NAFLD model)
were not injected with BDCM and served as controls against high-fat diet-fed BDCMinjected wild-type mice (NAFLD + BDCM mice). A group of chow diet fed LC mice was
also treated with the same dose of BDCM for 1 mo (LC + BDCM mice). LC mice not
injected with BDCM were used as a control against the LC + BDCM model.
Inhibition of CYP2E1 by DAS (CYP2E1 inhibitor): A set of high-fat diet-fed BDCM
treated mice was administered with 50 mg/kg DAS (diluted in corn oil) via an
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intraperitoneal injection at twice a week for 1 mo. This group was termed the NAFLD +
BDCM + DAS group.
Cell culture: A kidney MC line (CRL-1927) and kidney tubular cell line (CRL-2038) were
purchased from the American Type Culture Collection (Manassas, VA) and maintained in
DMEM (Corning, Tewksbury, MA) and DMEM-F-12 (1:1, American Type Culture
Collection), respectively. Media were supplemented with 10% FBS (Atlanta Biologicals,
Norcross, GA), 2 mM glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin
(GIBCO, Grand Island, NY) at 37°C in a humidified atmosphere of 5% CO2. MCs were
treated with 1 μM 4-HNE (Cayman Chemicals, Ann Arbor, MI) for 48 h, and equal
amounts of ethanol were added to control plates. The diluent for 4-HNE and the media
were collected for further experiments. Tubular cells were cultured in six well plates. After
allowing for the attachment of cells, the media were changed to obtain the following
groups: the control group containing fresh DMEM, the control group with DMEM and 1
μM 4-HNE, media collected from MCs treated with alcohol only, and media collected from
MCs treated with 1 μM 4-HNE for 48 h. Cells were then lysed in TRIzol (Invitrogen, Grand
Island, NY) for mRNA extraction. Cells were plated on coverslips by putting the coverslips
on each well of the six-well plates, maintaining the aforementioned conditions, and cells
adhered on coverslips were used for immunofluorescence staining after completion of the
treatment. To perform the apoptosis assay, tubular cells were seeded in 2-cm2 dishes with
attached coverslips (MatTek, Ashland, MA). After attachment, the media were changed to
give the groups described above for 48 h.
Immunohistochemistry: Kidneys were collected from each animal and fixed in 10%
neutral buffered formalin (Sigma-Aldrich). These formalin-fixed paraffin-embedded
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tissues were cut into 5-μm-thick sections. These sections were deparaffinized using a
standard protocol (35). Epitope retrieval of the deparaffinized sections was performed
using epitope retrieval solution and steamer (IHC-World, Woodstock, MD) following the
manufacturer's protocol. H2O2 (3%) was used for 5 min to block endogenous peroxidases.
Primary antibodies, such as anti-CD4, anti-CD8, anti-4-HNE, anti-IL-1β, anti-TNF-α, antiIFN-γ, anti-HMGB1, anti-CXCL16, anti-TGF-β, and anti-α-SMA, were used in the
recommended dilutions. Species-specific biotinylated conjugated secondary antibody and
streptavidin conjugated with horseradish peroxidase were used to perform antigen-specific
immunohistochemistry following the manufacturer's protocols. 3,3′Diaminobenzidine
(Sigma-Aldrich) was used as a chromogenic substrate. Tissue sections were counterstained
using Mayer's hematoxylin (Sigma-Aldrich). PBS was used as wash three times between
the steps. Sections were finally mounted in Simpo mount (GBI Laboratories, Mukilteo,
WA) and observed under ×20 and ×60 objectives using an Olympus BX51 microscope
(Olympus America, Center Valley, PA). Morphometric analysis was done using CellSens
Software from Olympus America. For immunohistochemical dual labeling of α-SMA-IL1β and α-SMA-TGF-β, the primary antibodies were used as described above. After epitope
retrieval, those deparaffinized sections with an Enzo immunohistochemical dual labeling
kit (Farmingdale, NY) were used following the manufacturer's protocol.
Picrosirius red staining: Picrosirius red staining of kidney slices was done using a Nova
ultra-sirius red stain kit following manufacturer's instructions (IHC-World). Sections were
observed using a ×20 objective under a light microscope.
Immunofluorescence: Formalin-fixed paraffin-embedded tissues sections were subjected
to deparaffinization using a standard protocol. Epitope retrieval of the deparaffinized
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sections was done using epitope retrieval solution and steamer (IHC World) following the
manufacturer's instructions. The primary antibody F4/80 (Abcam) as used at the
recommended dilution. Species-specific anti-IgG secondary antibodies conjugated with
Alexa fluor 633 (Invitrogen) were used. Sections were mounted in a ProLong gold antifade
reagent with 4′,6-diamidino-2-phenylindole (Life Technologies, Eugene, OR). Images
were taken under a ×10 objective using the Olympus BX51 microscope. After cells were
plated and treatments were completed as described above, cells attached on coverslips were
fixed using 10% neutral buffered saline. Cells were washed with PBS containing 0.1%
Triton X-100 (Sigma) and then blocked using 3% BSA, 0.2% Tween 20 (Fisher), and 10%
FBS in PBS. Cells were incubated with α-SMA primary antibody (Abcam) followed by
species-specific Alexa fluor 488 (Invitrogen) for immunofluorescence dual labeling
staining. Stained cells attached on coverslips were mounted on slides using ProLong gold
antifade reagent with 4′,6-diamidino-2 phenylindole (Life Technologies) and viewed under
a ×10 objective using the Olympus BX51 microscope.
Quantitative real-time PCR: Gene expression (mRNA) levels in kidney tissue samples
were measured by quantitative real-time RT-PCR. Total RNA was isolated from mouse
kidney tissues, and cells were treated using TRIzol reagent (Life Technologies) following
the manufacturer's protocol. RNA was purified using RNeasy mini kit columns (Qiagen,
Valencia, CA). An iScript cDNA synthesis kit (Bio-Rad) was used to convert 1 μg of
purified RNA to cDNA. Quantitative real-time RT-PCR was performed with gene specific
primers using SsoAdvanced Universal SYBR Green supermix (Bio-Rad) and a CFX96
thermal cycler (Bio-Rad). Threshold cycle (Ct) values for genes of interest were
normalized against 18S (internal control) values in the same sample. Reactions were
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carried out in triplicate for each gene and each tissue sample. The relative fold change was
calculated by the 2−ΔΔCt method. The sequences for the mouse-specific primers.
Table 2.1: Table showing the primer sequences for the different targets genes.
Gene
IL-1β

Sense

Antisense

CCTCGGCCAAGACAGGTC

TGCCCATCAGAGGCAAGGAGGA

GC
TNFα

CAACGCCCTCCTGGCCAAC TCGGGGCAGCCTTGTCCCTT
G

IFNγ

TGCGGGGTTGTATCTGGGG GCGCTGGCCCGGAGTGTAG
GT

α-SMA

GGAGAAGCCCAGCCAGTC

ACCATTGTCGCACACCAGGGC

GC
CD4

CACACACCTGTGCAAGAA

GCGTCTTCCCTTGAGTGACA

GC
CD8

GCCCTTCTGCTGTCCTTGA

TAGTTGTAGCTTCCTGGCGG

T
FasL

GCAGCAGCCCATGAATTA

AGATGAAGTGGCACTGCTGTCT

CC

AC

TUNEL assay: Paraffin-embedded mouse kidney tissue sections (5 μm thick) were used
for a TUNEL assay using an Apoptag Fluorescein In-Situ Apoptosis Detection Kit
(Millipore, Temecula, CA) following the manufacturer's protocol. Tissue sections were
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counterstained with propidium iodide in antifade reagent (Millipore). Stained sections were
imaged at magnification of ×20 using the Olympus BX51 microscope. Tubular cells were
grown in 2-cm2 dishes in the conditions described above. Attached cells were used for the
TUNEL assay using the Apoptag Fluorescein In Situ Apoptosis Detection Kit (Millipore)
following the manufacturer's protocol. Propidium iodide in antifade reagent (Millipore)
was used as a counterstain. Stained cells were imaged using a ×20 objective.
BUN assay: Blood urea nitrogen (BUN) was measured (in mg/dl) in mouse serum samples
using a BUN colorimetric detection kit (Arbor Assays) following the manufacturer's
instructions.
Renal inflammation and fibrosis scores: A blind folded analysis of renal pathology was
carried out to assess renal inflammation and fibrosis using a standard grading system. To
analyze tubulointerstitial fibrosis in the renal compartments, lesions were scored using a
semiquantitative scoring system (105). For inflammation, grade 0 = no foci of
inflammation, grade 1 = less than one foci per two ×20 fields, grade 2 = 1 foci per two ×20
fields to one foci per one ×20 fields, grade 3 = one to two foci per one ×20 fields, and grade
4 = more than two foci per one ×20 fields. Interstitial fibrosis was graded according to the
following scale: 0 = no evidence of interstitial fibrosis, 1 = less than 25% involvement, 2
= 25–50% involvement, and 3 = less than 50% involvement.
Statistical analyses: Statistical analysis was done by ANOVA followed by Bonferroni
post hoc correction for intergroup comparisons. P values of <0.05 were considered
statistically significant.
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2.3 RESULTS
NAFLD potentiates metabolic oxidative stress via CYP2E1 and caused increased lipid
peroxidation in proximal tubular cells. NAFLD shows increased CYP2E1 induction (66).
We have previously shown that metabolic oxidative stress in NAFLD/NASH causes lipid
peroxidation primarily dependent on CYP2E1 in the liver (35). BDCM is a substrate of
CYP2E1 and is known to cause lipid peroxidation through reductive metabolism (35). The
results showed that lipid peroxidation marker 4-HNE was significantly higher in the
NAFLD + BDCM kidney group compared with the LC, LC + BDCM, or NAFLD alone
groups (P < 0.05; Fig. 1, A and B). Mice treated with the CYP2E1 inhibitor DAS, a
relatively specific inhibitor of CYP2E1, showed a significant decrease in lipid
peroxidation, as assessed by decreased staining of 4-HNE. Peroxidation was primarily
localized in proximal tubular cells and podocytes (Fig. 1A). The results suggested that a
condition of NAFLD characterized by increased steatosis and metabolic oxidative stress
via CYP2E1 exacerbated the lipid peroxidation in the NAFLD + BDCM kidney group and
was not a result of the metabolism of the toxin alone since kidneys from the LC + BDCM
group had significantly decreased 4-HNE staining compared with the NAFLD + BDCM
group (Fig. 1A).
CYP2E1 metabolism in NAFLD causes increased secretion of proinflammatory
cytokines in renal proximal tubules.
Oxidative stress due to reductive metabolism of CYP2E1 has been shown to increase
proinflammatory cytokine release (35). We studied the role of CYP2E1 reductive
metabolism and its corresponding lipid peroxidation in the release of proinflammatory
cytokines in NAFLD kidneys after BDCM administration. The results showed that there
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was a significant increase in the levels of IL-1β in the LC+BDCM group compared with
the LC group (P < 0.05; Fig. 2B). Levels of the cytokine also increased in the NAFLD +
BDCM group compared with the NAFLD alone group (Fig. 2, A and B), as shown by
immunohistochemistry, compared with the NAFLD alone group, whereas the
administration of DAS significantly decreased levels of IL-1β primarily in proximal
tubular cells (Fig. 1, A and B). mRNA expression of IL1β also showed a significant
increase in the NAFLD + BDCM group compared with NAFLD alone group, whereas the
NAFLD + BDCM + DAS group showed a significant decrease in mRNA levels, as assessed
by quantitative RT-PCR (Fig. 2C). Oxidative stress and other inflammatory stimuli of a
primarily systemic nature have been shown to increase TNF-α levels and TNF-α release
from proximal tubular cells, podocytes, and MCs (76, 87, 91, 97). The results showed that
levels of TNF-α were significantly increased primarily in tubular cells, podocytes, and MCs
in the NAFLD + BDCM group compared with the NAFLD alone group (P < 0.05; Fig. 2,
D and E). No significant change was observed between the LC and LC + BDCM groups.
The administration of DAS significantly decreased TNF-α levels compared with the
NAFLD + BDCM group (P < 0.05; Fig. 2, D and E). The increased protein levels were due
to increased protein synthesis, as explained by the increased mRNA expression of the
cytokine in the NAFLD + BDCM group compared with the NAFLD alone group or DASadministered group (P < 0.05; Fig. 2F). Although the proinflammatory cytokines IL-1β and
TNF-α were found to be increased in proximal tubular cells in the NAFLD + BDCM group,
we investigated the role of IFN-γ, a regulatory cytokine, in the kidney. IFN-γ has been
found to often be associated with a regulatory role in the kidney, especially by suppressing
angiotensinogen levels via suppressor of cytokine signaling 1 (99). To study the role of
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CYP2E1-mediated oxidative stress in regulating the role of IFN-γ, immunohistochemistry
was performed. The results showed that IFN-γ protein was primarily localized in proximal
tubular cells and other cell types (Fig. 2G). Levels of IFN-γ were significantly increased in
the NAFLD + BDCM group compared with the NAFLD alone group, whereas only a slight
but significant change was observed between LC and LC + BDCM groups (P < 0.05; Fig.
2, G and H). The administration of DAS significantly decreased IFN-γ levels in these cells
compared with the NAFLD + BDCM group (P < 0.05; Fig. 2H). mRNA expression of IFNγ also showed a significant increase in the NAFLD + BDCM group compared with both
the NAFLD alone group and DAS-administered group (P < 0.05; Fig. 2I), confirming that
the increase in the levels of IFN-γ was because of increased mRNA expression and most
likely by increased protein synthesis. The results assumed significance since IFN-γ can be
secreted from infiltrating or resident T cells, including NKT cells, which have been shown
to be protective in various forms of glomerulonephritis (107).
NAFLD-induced CYP2E1 metabolism leads to increased MC proliferation and TGFβ production.
MCs have long been regarded as mediators of CKD (81). Hypertrophy of MCs and tubular
cells is common in the progression of CKD (81). To study the involvement of MC
activation, proliferation and hypertrophy in the NAFLD potentiation of CYP2E1-induced
oxidative stress, and the subsequent immunotoxicity in the kidney, protein levels and
localization of α-SMA were analyzed by immunohistochemistry (79). The results showed
that there was a significant increase in the immunoreactivity of α-SMA in the glomerulus
and proximal tubular cells in the NAFLD + BDCM group compared with the NAFLD alone
group, whereas no significant change was observed between LC and LC + BDCM groups
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(P < 0.05; Fig. 3, A and B). DAS-administered mice had a significant decrease in
immunoreactivity to α-SMA compared with the NAFDLD + BDCM group (P < 0.05, Fig.
3, A and B). mRNA expression of α-SMA was significantly higher in the NAFLD + BDCM
group compared with both the NAFLD alone group or DAS-administered group,
suggesting that the protein synthesis of α-SMA was intrinsic to the kidney (P < 0.05; Fig.
3C). Since MC-mediated fibroproliferative effects, especially mesangial matrix formation,
are via TGF-β production, we studied the immunoreactivity of TGF-β in the glomerulus
and proximal tubular cells (83, 86). The results showed that the NAFLD + BDCM group
showed significantly higher protein levels of TGF-β compared with the NAFLD alone
group, whereas DAS administration significantly decreased TGF-β immunoreactivity
compared with the NAFLD + BDCM group (P < 0.05; Fig. 3, D and E). Interestingly, the
LC + BDCM group showed a significant increase in the level of the cytokine compared
with the LC group (Fig. 3E). There was increased mRNA expression of TGF-β in the
NAFLD + BDCM group compared with the NAFLD alone group or NAFLD + DAS group
(P < 0.05; Fig. 3F). The results suggest that MC proliferation, in part, is a significant event
in NAFLD potentiation of immunotoxicity, although other cell types cannot be ruled out
at this stage. MCs incubated with 4-HNE showed increased expression of IL-1β, TNF-α,
PDGF2, TLR4, and α-SMA (Fig. 3, G–K). α-SMA protein expression and its
myofibroblastic phenotype were also evident by immunofluorescent microscopy in the 4HNE-treated group compared with the cells + vehicle-treated group (Fig. 3L).
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NAFLD potentiation of immunotoxicity via CYP2E1-mediated oxidative stress
increases T cell presence in the renal microenvironment.
Differential roles of various T cell subsets have been reported in CKD (89). Our previous
data in this study showed an increased IFN-γ immunoreactivity in the NAFLD + BDCM
group, whereas administration of DAS had decreased protein levels of this T cell cytokine
(Fig. 2, G–I). To study the presence of T cells in the NAFLD kidney after increased
CYP2E1-mediated oxidative stress, quantitative real-time PCR was used to analyze the
fold expression of CD4, CD8, Va14, and NK1.1 genes. The results showed that mRNA
expression of CD4, CD8, Va14, and NK1.1 was significantly higher in the NAFLD +
BDCM group compared with the NAFLD alone group (P < 0.05; Fig. 4, A–D), whereas
the administration of DAS significantly decreased mRNA expression of T cell subset
markers in the kidney. Interestingly, use of CD1D KO mice, which were deficient in CD1ddependent NKT cells, had significantly decreased mRNA expression of Va14, CD4, and
CD8, whereas the expression of NK1.1 was unchanged (P < 0.05; Fig. 4). Expression of
Va14 was significantly higher in the NAFLD + DAS group, suggesting that CYP2E1
reductive metabolism might have a role in the repression of invariant NKT cells and that
the administration of DAS significantly upregulated NKT cell expression of Va14 (Fig.
4C). However, protein expression of CD4 and CD8 was significantly higher in CD1d KO
mice, despite the low mRNA expression of these T cell markers (Fig. 4, E and F). The
observed data of higher CD4 and CD8 protein in CD1d KO mice might be due to other T
cell subsets in CD1d KO mice. To show the presence of infiltrating macrophages, F4/80
immunofluorescence staining was performed. The results showed that there was no marked
difference between groups. The reactivity was also diffused due to the presence of red
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blood cells in the kidney (Fig. 4G). These data thus suggested that CD1d-dependent NKT
cells with CD4 and/or CD8 expression might be involved, although in part, in the
modulation of immunotoxicity in the NAFLD kidney.
Proximal tubule immunotoxicity in NAFLD potentiation of CYP2E1-mediated renal
inflammation is exacerbated in mice deficient in NKT cells.
Based on the data of increased T cell presence in the NAFLD kidney and the increased
expression of CD4, CD8, and Va14, we used mice deficient in CD1D-specific NKT cells
to study the role of these T cell subsets in the NAFLD kidney. The results showed that the
proinflammatory cytokines IL1-β and TNF-α were localized in proximal tubular cells and
were significantly higher in CD1D KO mouse kidneys compared with the NAFLD +
BDCM group (P < 0.05; Fig. 5, A, B, D, and E). The increase was three- to fourfold higher
in CD1D-deficient mice. mRNA expression of the cytokines IL-1β and TNF-α was also
significantly higher in CD1D KO mice (3.5-fold), suggesting an intrinsic response from
the cells, most likely NKT cells dependent on CD1D (P < 0.05; Fig. 5, C and F). The results
strongly suggested that the absence of CD1D significantly exacerbated the NAFLD kidney
immunotoxicity. However, the increased CD4 and CD8 protein in CD1D KO mice and
their strong correlation with tubular immunotoxicity in the absence of CD1D-dependent
NKT cells might possibly be due to infiltrating and/or resident T cells, which are capable
of increasing cytotoxicity. The study also analyzed the expression of NAFLD kidney
secretion of PDGF2 and TLR4. Since there was a strong indication of the activation of
MCs and the proinflammatory pathway that is downstream of TLR4 signaling, such as IL1β and TNF-α, expression of both PDGF2 and TLR4 was performed. The results showed
that mRNA expression of TLR4 was significantly higher in the NAFLD + BDCM group
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but was lower in the NAFLD + BDCM + DAS group (Fig. 5G). CD1D-deficient mice had
a significant increase in the expression of TLR4 compared with the NAFLD + BDCM
group (P < 0.05; Fig. 5G). Interestingly, BDCM administration to LC mice did not
significantly increase the expression of TLR4 or PDGF2 compared with the LC alone
group (Fig. 5, G and H). The results suggested that the expression of TLR4 correlated well
with CD1D deficiency and tubular immunotoxicity. MC activation is often associated with
an increase in PDGF2 (79, 97). The results showed that PDGF2 expression was
significantly higher in the NAFLD + BDCM group compared with the NAFLD alone group
(P < 0.05; Fig. 5H). The administration of DAS significantly decreased its expression,
whereas lack of CD1D had a significant increase in its expression compared with the
NAFLD + BDCM group (P < 0.05; Fig. 5H). The results suggested that MC activation and
the release of proinflammatory mediators were strong possibilities due to a reductive
metabolism of CYP2E1 and NKT cell deficiency intrinsic to the kidney in addition to
infiltrating T cell subsets (CD4+ and CD8+) might be regulating its activation and
immunotoxicity.
MC proliferation and TGF-β production were increased in mice deficient in NKT
cells.
To show that CD1D-dependent NKT cells regulated the MC proliferation, we studied the
protein levels of α-SMA and TGF-β in the NAFLD kidney. The results showed that
immunoreactivity of α-SMA and TGF-β were significantly increased in the NAFLD +
BDCM group compared with the NAFLD alone group (P < 0.05; α-SMA: Fig. 6, A and C,
and TGF-β: Fig. 6, B and D), whereas mice deficient in CD1D-dependent NKT cells
showed a significant increase in both α-SMA and TGF- β immunoreactivity compared with
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the NAFLD + BDCM group. Dual labeling of IL1β/α-SMA and TGF-β/α-SMA showed a
significant increase in immunoreactivity in CD1D KO mice. Interestingly, mice lacking T,
B, and NK cells showed a significant decrease in α-SMA levels. The results suggested that
MC activation (α-SMA + ve cells), at least in part, is dependent on the presence of NKT
cells and that lack of NKT cells significantly enhanced immunotoxicity. In the absence of
T, B, or NK cells, there was no significant increase in MC activation (Fig. 6, E,v and F,v).
NAFLD potentiation of renal inflammation induced by MCs causes increased levels
of proximal tubular HMGB1 levels and apoptosis in part via the TLR4 pathway with
exacerbation after lack of CD1D-dependent NKT cells.
Our results showed that MCs were activated after CYP2E1-induced oxidative stress.
Reductive metabolism of CYP2E1 has been shown to cause cell death and the release of
DAMPs in the circulation (39). HMGB1 is known to be an established DAMP and a ligand
for TLR4 activation (73, 82). Our previously described results in this study have shown
TLR4 activation in the NAFLD kidney that was dependent on CYP2E1 reductive
metabolism and the presence of CD1D. To show the presence of HMGB1 in the NAFLD
kidney, we studied the immunoreactivity of HMGB1 in kidney tissues. The results showed
that HMGB1 immunoreactivity was significantly higher in the NAFLD + BDCM group
compared with the NAFLD alone group (P < 0.05; Fig. 7, A and B), whereas deficiency of
CD1D significantly increased HMGB1 protein in this group compared with the NAFLD +
BDCM group (P < 0.05; Fig. 7, A and B). Further apoptotic cell death, as indicated by
TUNEL-positive nuclei, was significantly increased in the NAFLD + BDCM group
compared with the NAFLD alone group (P < 0.05; Fig. 7, C and D). Deficiency of CD1D
further increased apoptosis compared with the NAFLD + BDCM group (Fig. 7, C and D).
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These results suggested that increased HMGB1 was partly due to the repression of NKT
cell function in NAFLD and may be responsible for the proinflammatory surge in the
kidneys. Interestingly, apoptosis indicated by TUNEL assay also followed a similar
pattern, being controlled in part by NKT cells intrinsic to the kidneys. The apoptosis might
be mediated by CD95L (Fas ligand) since mRNA expression was significantly higher in
the NAFLD + BDCM group compared with the NAFLD alone group, whereas CD1Ddeficient mice had a further increase in the expression of Fas ligand (P < 0.05; Fig. 7E). To
show the role of MCs in proximal tubular immunotoxicity, conditioned medium from MCs
was used to incubate proximal tubular cells. The results showed that proximal tubular cells
had a significant increase in chemokine (C-C motif) ligand 5 (regulated on activation,
normal T cell expressed and secreted) and endothelin-1 expression (P < 0.05; Fig. 7, F and
G). Tubular cells also had a significant increase in the expression of IL-1β and monocyte
chemoattractant protein-1 (Fig. 7, H and I). These cells also exhibited more apoptotic cell
death, as indicated by increased TUNEL-positive nuclei (shown by yellow; Fig. 7J). The
data showed that activated MCs caused tubular cell toxicity.
Exacerbation of immunotoxicity in NAFLD kidneys after reductive metabolism of
CYP2E1 is mediated by TLR4 activation.
A significant role of CYP2E1 in inflammation has been documented (67). The
mechanisms, although unclear, might proceed through an oxidative stress-DAMP-TLR4
signaling pathway. To study whether the strong correlation of the events that we observed
in the NAFLD kidney might be via TLR4 signaling, we used TLR4 KO mice kidneys
treated identically. The results showed that the immunotoxicity was significantly decreased
in TLR4 KO mouse kidneys compared with the NAFLD + BDCM group for IL-1β, TNF28

α, and Fas ligand, whereas the expression of IL-6 was unchanged (P < 0.05; data not shown
and Fig. 8A). LC mice treated with BDCM had a marked increase in the expression of Fas
ligand compared with the LC group and NAFLD + BDCM group (Fig.8A). HMGB1
immunoreactivity was unchanged in TLR4 KO mice, indicating that HMGB1 was
upstream of TLR4 signaling, as may be perceived since HMGB1 is a known inducer of
TLR4 signaling (Fig. 8, B and C). The results suggested a strong involvement of TLR4
signaling in the immunotoxicity of the kidney of mice that had NAFLD and CYP2E1
activation.
Exacerbation of immunotoxicity in NAFLD kidneys by reductive metabolism of
CYP2E1 increases the levels of CXCL16.
CXCL16 has been shown to be a proinflammatory mediator mostly released by dendritic
cells and is bound by NKT cells through their surface moiety CXCR6 (96). To show
whether CYP2E1 reductive metabolism in NAFLD causes an increase in levels of CXCL16
in the kidneys, we performed immunohistochemistry and mRNA expression profiles of
this important cytokine. The results showed that there was a significant increase in the
immunoreactivity of CXCL16 in the NAFLD + BDCM group compared with the NAFLD
alone group (P < 0.05; Fig. 9, A and B). The administration of DAS significantly decreased
the immunoreactivity of CXCL6, whereas CD1D-deficient mouse kidneys did not show
any significant difference (P < 0.05). mRNA expression of CXCL16 also showed a similar
trend while indicating that the expression was intrinsic to the kidneys (P < 0.05; Fig. 9C).
These results suggested that there might be a strong correlation with increased CXCL16 in
the kidneys and increased NKT cell activation, as shown in this study, because NKT cells
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are attracted due to the higher presence of cognate ligand and chemokine (CXCL16) in the
renal microenvironment (96).
NAFLD-induced CYP2E1 activity and metabolic oxidative stress cause kidney injury
and affect glomerular function.
To show whether CYP2E1-mediated oxidative stress affected glomerular function, mouse
blood was analyzed for BUN concentrations as an indicator of glomerular function. The
results showed that BUN increased significantly in the LC + BDCM group compared with
the LC alone group (P < 0.05; Fig. 10A). The administration of the CYP2E1 inhibitor
showed a significant decrease in BUN values. However, an underlying condition of
NAFLD and metabolic oxidative stress significantly increased the concentration of BUN
(>3-fold) compared with the NAFLD alone or LC groups (Fig. 10A). Picrosirius red
staining, an indicator of collagen deposition, showed a marked increase in the NAFLD +
BDCM group compared with the NAFLD alone group, whereas administration of the
CYP2E1 inhibitor attenuated the collagen deposition (Fig. 10B). Histological scores
showed that the NAFLD + BDCM group had higher inflammation fibrosis than the
NAFLD alone group, whereas the CD1D KO group showed higher scores for these two
indexes compared with the NAFLD + BDCM group. TLR4 KO mice had lower
inflammation and fibrosis.
2.4 DISCUSSION
In the present study, we show that an underlying condition of progressive NAFLD in mice
exacerbated proximal tubular immunotoxicity and affected glomerular function after a
second hit from metabolic oxidative stress via CYP2E1. The heightened inflammation in
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proximal tubular cells might have resulted from MC proliferation, as indicated by increased
α-SMA protein and increased TGF-β production (76, 92). Furthermore, the heightened
inflammation was mediated in part by a TLR4-dependent mechanism, as shown by the
abrogation of the inflammatory phenotype in TLR4 KO mouse kidneys. Finally, the study
showed that the proinflammatory nature of the immunotoxicity in NAFLD kidneys that
had metabolic oxidative stress via CYP2E1 metabolism was modulated by NKT cells, as
evidenced by 1) increased immunotoxicity in NKT cell-deficient mice and 2) higher
localization of CXCL16 protein, a ligand that binds to CXCR6 on NKT cells to promote
its activation in the kidneys (96).
There is increasing evidence that a condition of NAFLD, which has high risks of
progressing to NASH, cirrhosis, and hepatocellular carcinoma, can have comorbidities that
may include renal and cardiovascular complications (72). The more progressive form of
NAFLD is termed NASH and is likely caused by a second or multiple hits from oxidative
stress, inflammatory adipokines, activation of pattern recognition receptors, glucose
intolerance, and insulin resistance (69). More recently, there have been significant studies
that have shown the role of CYP2E1 in modulating the progression of NAFLD to NASH
via metabolic oxidative stress (66, 84, 85, 93). In the present study, we used BDCM as a
substrate for the generation of metabolic oxidative stress that aids in the progression of
NASH (88). Interestingly, CYP2E1 reductive metabolism of BDCM caused lipid
peroxidation in proximal tubular cells of the kidney, as shown by 4-HNE staining, whereas
the administration of DAS, a specific inhibitor of CYP2E1, attenuated the peroxidation.
The increased oxidative stress was not due to the toxin administration alone since LC mice,
which did not have symptoms of NAFLD and did not have steatosis or insulin resistance,
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did not show the exacerbation in oxidative stress. The results strongly suggested that
CYP2E1-mediated oxidative stress in the liver might be a strong mediator of ectopic
manifestations in distant organs, such as the kidney, via soluble mediators of inflammation
or DAMPs that can be released in the circulation and further cause lipid peroxidation in
the kidneys (73, 106). It is highly unlikely that the toxin alone could cause a parallel
oxidative stress damage in the kidneys via CYP2E1 metabolism since it is known that the
kidneys possess only 5% of CYP2E1 protein compared with the liver (98). However, the
mechanisms were elusive at this juncture.
Metabolic syndrome and diabetes have been found to be among the many reasons
responsible for CKD (77). CKD is often associated with proximal tubular inflammation,
glomerulonephritis, and glomerulosclerosis. Our study investigated the proinflammatory
events in the glomerulus and proximal tubules after progressive NAFLD (NAFLD with
inflammation and fibrosis in the liver) in mice. Furthermore, we aimed at identifying the
cell types that might be primarily responsible for the heightened proinflammatory
phenotype by targeting MCs, since it has been shown that MCs have a strong role to play
in the development of CKD (83). The results showed that there was a significant increase
in the levels of lipid peroxidation, IL-1β, and TNF-α in proximal tubular cells and
podocytes. There was a significant increase in the levels of α-SMA, a proliferative marker
of MCs, along with levels of TGF-β. Interestingly, levels of IFN-γ and the T cell markers
CD4, CD8, and Va14 (an invariant NKT cell marker) were also increased in proximal
tubules. The strong inflammatory phenotype and increased levels of α-SMA and TGF-β
levels showed a strong bias toward the role of MCs in proinflammatory processes in the
tubule, but a role of endothelial cells also could not be ruled out (101). The rationale that
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MC activation caused proximal tubular immunotoxicity was further strengthened by results
where conditioned medium from MCs enhanced tubular cell expression of
proinflammatory cytokines and cell death (Fig. 7, F–J). It was highly unlikely that the
infiltrating macrophages were responsible since there was equal F4/80 staining in kidney
sections, including the CD1D KO group (Fig. 4G).
The data showed a prominent inflammatory pattern in tubules, but the presence of
T cells also increased the possibility of a regulatory role of these cells in the kidney after
NAFLD progression. The argument in favor of the regulatory role of T cells could not be
ignored since glomerulonephritis has been shown to be attenuated by the presence of NKT
cells primarily in the kidney (107). Moreover, the significant increase in the mRNA
expression of Va14, a marker of invariant CD1D-dependent NKT cells, also indicated the
involvement of these cell types (107). We used CD1D KO mice to probe the involvement
of NKT cells since use of mice that were deficient for T, B, and NK cells did not alter the
immunotoxic phenotype in the kidneys, especially regarding the activation of MCs (Fig. 6,
E and F). The use of CD1D KO mice significantly exacerbated the proinflammatory
phenotype in the kidneys by three- to fourfold compared with the NAFLD + BDCM group
(which harbors the kidney disease phenotype).
Ectopic manifestation of the effects of progressive NAFLD, especially in
conditions of NASH, has been shown (72). DAMPS can be released in the circulation after
liver injury (39). HMGB protein, adipokine leptin, or TNF-α in the circulation has been
shown to cause lipid peroxidation in distant organs (102). Furthermore, HMGB1 can act
as an endogenous ligand for TLR4 receptors and increase immunotoxicity (75). Our data
showed increased levels of HMGB1 protein in proximal tubular cells, whereas lack of NKT
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cells showed a further increase in the levels of HMGB1, suggesting a modulatory role of
NKT cells in preventing DAMP-induced kidney injury. However, the exact mechanism by
which NKT cells can modulate the release of DAMPs is not understood in this study. To
show whether HMGB1 mediated the proximal tubular inflammation through the TLR
pathway, we used TLR4 KO mice. The results indicated that the mRNA expression of IL1β and TNF-α was significantly decreased in TLR4 KO mouse kidneys, suggesting a strong
involvement of TLR4 pathway activation, probably through endogenous ligands. However,
the data are clearly of an indicative nature since endotoxin leaching via the gut could not
be ruled out, as has been predicted in alcoholic liver disease (104).
Taken together, we report a possible mechanistic investigation of ectopic
immunotoxicity in kidney proximal tubular cells after heightened CYP2E1 metabolism in
progressive NAFLD. The increased oxidative stress caused MC activation and
proinflammatory cytokine release, thus accentuating extracellular matrix formation via
TGF-β production. The resultant immunotoxicity possibly mediated the altered glomerular
function, as indicated by increased BUN values. The proinflammatory events were likely
mediated by the TLR4 pathway, and the presence of NKT cells was found to be protective
in the NAFLD potentiation of proximal tubular immunotoxicity. On the other hand, NKT
cells, which might be activated in parallel by oxidative stress, played a major protective
role via binding to CXCL16, which also has been shown in this study to be increased in
the kidneys after reductive metabolism of CYP2E1. Future studies will need to focus on
both DAMP-induced TLR4 pathway activation and a concomitant regulatory mechanism
by CD1D-dependent NKT cells or other regulatory T cells.
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Figure2.1A: 4-hydroxynonenal (4-HNE; a marker for lipid peroxidation)
immunoreactivity, as shown by immunohistochemistry in kidney slices from mice fed a
chow diet [lean control (LC); i], LC mice exposed to bromodichloromethane (BDCM; ii),
mice fed a high-fat diet (60% kcal fat) and used as a model of nonalcoholic fatty liver
disease (NAFLD; iii), NAFLD mice exposed to BDCM (iv), and NAFLD mice coexposed
to BDCM and diallylsulfide (DAS; v), a known cytochrome P-450 (CYP)2E1 inhibitor.
Images were taken at ×20 magnification. B: morphometric analysis of 4-HNE
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immunoreactivity (mean data from 3 separate microscopic fields were plotted on the yaxis)
in the LC, LC + BDCM, NAFLD, NAFLD + BDCM, and NAFLD + BDCM + DAS
groups. *P < 0.05.

Firgure 2.2A: immunoreactivity of IL-1β, as shown by immunohistochemistry in kidney
slices from LC(i), LC + BDCM (ii), NAFLD (iii), NAFLD + BDCM (iv), and NAFLD +
BDCM + DAS (v) groups of mice. B: morphometric analysis of IL-1β immunoreactivity
in the LC, LC + BDCM, NAFLD, NAFLD + BDCM, and NAFLD + BDCM + DAS
groups. *P < 0.05. C: mRNA expression of IL-1β in kidney tissue of LC, LC + BDCM,
NAFLD, NAFLD + BDCM, and NAFLD + BDCM + DAS groups of mice. D:
immunoreactivity of TNF-α, as shown by immunohistochemistry in kidney slices from LC
(i), LC + BDCM (ii), NAFLD (iii), NAFLD + BDCM (iv), and NAFLD + BDCM + DAS
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(v) groups of mice. E: morphometric analysis of TNF-α immunoreactivity in the LC, LC +
BDCM, NAFLD, NAFLD + BDCM, and NAFLD + BDCM + DAS groups. *P < 0.05. F:
mRNA expression of TNF-α in kidney tissue of LC, LC + BDCM, NAFLD, NAFLD +
BDCM, and NAFLD + BDCM + DAS groups of mice. G: immunoreactivity of interferon
(IFN)-γ, as shown by immunohistochemistry in kidney slices from LC (i), LC + BDCM
(ii), NAFLD (iii), NAFLD + BDCM (iv), and NAFLD + BDCM + DAS (v) groups of
mice. H: morphometric analysis of IFN-γ immunoreactivity in the LC, LC + BDCM,
NAFLD, NAFLD + BDCM, and NAFLD + BDCM + DAS groups. *P < 0.05. F: mRNA
expression of IFN-γ in kidney tissue of LC, LC + BDCM, NAFLD, NAFLD + BDCM, and
NAFLD + BDCM + DAS groups of mice. All immunohistochemistry images were taken
at ×20 magnification, and morphometric analysis results were plotted as mean data
(immunoreactivity measured in arbitrary light units) from three separate microscopic fields
plotted on the y-axis. All mRNA expression was assessed by quantitative real-time PCR,
and expression was normalized against the LC group. *P < 0.05.
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Figure2.3 A: immunoreactivity of α-smooth muscle actin (α-SMA), as shown by
immunohistochemistry in kidney slices from LC(i), LC + BDCM (ii), NAFLD (iii),
NAFLD + BDCM (iv), and NAFLD + BDCM + DAS (v) groups of mice. All images were
taken at ×60 oil magnification. B: morphometric analysis of α-SMA immunoreactivity in
the LC, LC + BDCM, NAFLD, NAFLD + BDCM, and NAFLD + BDCM + DAS groups.
*P < 0.05. C: mRNA expression of α-SMA gene in kidney tissue of LC, LC + BDCM,
NAFLD, NAFLD + BDCM, and NAFLD + BDCM + DAS groups of mice. D:
immunoreactivity of transforming growth factor (TGF)-β, as shown by
immunohistochemistry in kidney slices from LC(i), LC + BDCM (ii), NAFLD (iii),
NAFLD + BDCM (iv), and NAFLD + BDCM + DAS (v) groups of mice. All images were
taken at ×20 magnification. E: morphometric analysis of TGF-β immunoreactivity in the
LC, LC + BDCM, NAFLD, NAFLD + BDCM, and NAFLD + BDCM + DAS groups. *P
< 0.05. F: mRNA expression of TGF-β in kidney tissue of LC, LC + BDCM, NAFLD,
NAFLD + BDCM, and NAFLD + BDCM + DAS groups of mice. Morphometric analysis
was plotted as mean data (immunoreactivity measured in arbitrary light units) from three
separate microscopic fields plotted on the y-axis. All mRNA expression was assessed by
quantitative real-time PCR, and expression was normalized against the LC group. *P <
0.05. G–K: mRNA expression of α-SMA, TNF-α, IL-1β, Toll-like receptor (TLR)4, and
PDGF2 in cell lysates of a kidney mesangial cell (MC) line (CRL-1927) treated with 4HNE, a lipid peroxidation product. MCs treated with ethanol were used as a control (CTL).
L: immunofluorescence images of CRL-1927 cells treated with either alcohol or 4-HNE
for assessment of myofibroblastic phenotype (αSMA immunoreactivity).
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Figure2.4 A–D: mRNA expression of CD4, CD8, Va14, and NK1.1 genes in kidney tissue
from LC, LC + BDCM, NAFLD, NAFLD + BDCM, NAFLD + BDCM + DAS groups of
mice as well as CD1d-deficient [CD1d knockout (KO)] mice fed a high-fat diet and
exposed to BDCM. mRNA expression was assessed by quantitative real-time PCR, and
expression was normalized against the LC group. *P < 0.05. E and F: immunoreactivity of
tissue sections against CD4 (E) and CD8 (F), as assessed by immunohistochemistry from
LC(i), LC + BDCM (ii), NAFLD (iii), NAFLD + BDCM (iv), NAFLD + BDCM + DAS
(v), and CD1d KO + BDCM (vi) groups of mice. G: immunofluorescence microscopy for
F4/80 immunoreactivity in kidney slices from LC (i), LC + BDCM (ii), NAFLD (iii),
NAFLD + BDCM (iv), and CD1d KO (v) groups, as shown by red fluorescence.
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Figure 2.5 A: immunoreactivity of IL-1β, as shown by immunohistochemistry in kidney
slices from NAFLD (i), NAFLD + BDCM (ii), and CD1d KO + BDCM (iii) groups. B:
morphometric analysis of IL-1β immunoreactivity in NAFLD, NAFLD + BDCM, and
CD1d KO + BDCM groups of mice. Data were normalized against the NAFLD group. *P
< 0.05. C: mRNA expression of IL-1β in kidney tissue of NAFLD, NAFLD + BDCM, and
CD1d KO + BDCM groups of mice. D: immunoreactivity of TNF-α, as shown by
immunohistochemistry in kidney slices from NAFLD (i), NAFLD + BDCM (ii), and CD1d
KO + BDCM (iii) groups. E: morphometric analysis of TNF-α immunoreactivity in
NAFLD, NAFLD + BDCM, and CD1d KO + BDCM groups of mice. Data were
normalized against the NAFLD group. *P < 0.05. F: mRNA expression of TNF-α in kidney
tissue of NAFLD, NAFLD + BDCM, and CD1d KO + BDCM groups of mice. G and H:
mRNA expression of TLR4 and PDGF2 in kidney tissue of LC, LC + BDCM, NAFLD,
NAFLD + BDCM, NAFLD + BDCM + DAS, and CD1d KO + BDCM groups of mice.
All immunohistochemistry images were taken at ×20 magnification, and morphometric
analysis was plotted as mean data (immunoreactivity measured in arbitrary light units)
from three separate microscopic fields plotted on the y-axis. All mRNA expression was
assessed by quantitative real-time PCR, and expression was normalized against the LC
group. *P < 0.05.
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Figure 2.6A: immunoreactivity of α-SMA, as shown by immunohistochemistry in kidney
slices from the NAFLD (i), NAFLD + BDCM (ii), and CD1d KO + BDCM (iii) groups.
B: immunoreactivity of TGF-β, as shown by immunohistochemistry in kidney slices from
the NAFLD (i), NAFLD + BDCM (ii), and CD1d KO + BDCM (iii) groups. C and D:
morphometric analysis of α-SMA (C) and TGF-β (D) immunoreactivity in NAFLD,
NAFLD + BDCM, and CD1d KO + BDCM groups of mice. All immunohistochemistry
images were taken at ×20 magnification, and morphometric analysis was carried out as
mean data (immunoreactivity measured in arbitrary light units) from three separate
microscopic fields plotted on the y-axis. *P < 0.05. E: immunohistochemistry images of
kidney tissue slices showing immunoreactivity against both α-SMA (red) and IL-1β
(yellow). F: immunohistochemistry images of kidney tissue slices showing
immunoreactivity against both α-SMA (red) and TGF-β (yellow).
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Figure 2.7A: immunoreactivity of high mobility group box (HMGB)1, as shown by
immunohistochemistry in kidney slices from LC (i), LC + BDCM (ii), NAFLD (iii),
NAFLD + BDCM (iv), and CD1d KO + BDCM (v) groups of mice. B: morphometric
analysis of HMGB1 immunoreactivity in LC, LC + BDCM, NAFLD, NAFLD + BDCM,
and CD1d KO + BDCM groups of mice. Mean data (immunoreactivity measured in
arbitrary light units) from three separate microscopic fields were plotted on the y-axis. *P
< 0.05. C: mumber of apoptotic nuclei as shown by TUNEL immunofluorescence staining
in kidney slices from LC (i), LC + BDCM (ii), NAFLD (iii), NAFLD + BDCM (iv), and
CD1d KO + BDCM groups of mice. The number of TUNEL-positive cells identified by
their green-stained nuclei against the nuclear fast red-stained nuclei corresponds to the
number of apoptotic events. Images were taken at ×20 magnification. D: percentage of
TUNEL-positive cells (obtained by morphometric analysis done on images from three
separate microscopic fields) in LC, LC + BDCM, NAFLD, NAFLD + BDCM, and CD1d
KO + BDCM groups. *P < 0.05. E: mRNA expression of Fas ligand (FasL) in kidney tissue
of LC, LC + BDCM, NAFLD, NAFLD + BDCM, and CD1d KO + BDCM groups of mice.
F–I: a kidney MC line (CRL-1927) and kidney tubular cell line (CRL-2038) were used for
these experiments. CRL-2038 cells were incubated with conditioned medium (CM) from
MC + 4-HNE. mRNA expression was then assessed by quantitative real-time PCR using
primers for chemokine (C-C motif) ligand 5, endothelin-1, IL-1β, and monocyte
chemoattractant protein (MCP)-1 (P < 0.05). J: cell death (apoptotic) as shown by TUNEL
(green)-stained nuclei (red). Nuclei positive for TUNEL show a yellow appearance and
were markedly higher in cells + CM + 4-HNE compared with the other groups.
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Figure 2.8 A: mRNA expression of IL-1β, IL-6, TNF-α, and FasL in kidney tissue of LC,
LC + BDCM, NAFLD, NAFLD + BDCM groups as well as TLR4 gene-deficient (TLR4
KO) mice fed a high-fat diet and exposed to BDCM. All mRNA expression was assessed
by quantitative real-time PCR, and expression was normalized against the NAFLD group.
*P < 0.05. B: immunoreactivity of HMGB1, as shown by immunohistochemistry in kidney
slices from LC (i), LC + BDCM (ii), NAFLD (iii), NAFLD + BDCM (iv), and TLR4 KO
+ BDCM (v) groups. All images were taken at ×20 magnification. All mRNA expression
was assessed by quantitative real-time PCR, and expression was normalized against the LC
group. *P < 0.05. C: immunoreactivity of HMGB1. *P < 0.0
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CHAPTER 3
HIGH CIRCULATORY LEPTIN MEDIATED NOX-2
PEROXYNITRITE-MIR21 AXIS ACTIVATE MESANGIAL CELLS
AND PROMOTES RENAL INFLAMMATORY PATHOLOGY IN
NONALCOHOLIC FATTY LIVER DISEASE
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Abstract:
High circulatory insulin and leptin followed by underlying inflammation is often ascribed
to the ectopic manifestations in non-alcoholic fatty liver disease (NAFLD) but the exact
molecular pathways remain unclear. We have shown previously that CYP2E1-mediated
oxidative stress and circulating leptin in NAFLD is associated with renal disease severity.
Extending the studies, we hypothesized that high circulatory leptin in NAFLD causes renal
mesangial cell activation and tubular inflammation via a NOX2 dependent pathway that
upregulates proinflammatory miR21. High fat diet (60%kcal) was used to induce fatty liver
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phenotype with parallel insulin and leptin resistance. The kidneys were probed for
mesangial cell activation and tubular inflammation that showed accelerated NASH
phenotype and oxidative stress in the liver. Results showed that NAFLD kidneys had
significant increases in α-SMA, a marker of mesangial cell activation, miR21 levels,
tyrosine nitration and renal inflammation while they were significantly decreased in leptin
and p47 phox knockout mice. Micro RNA21 knockout mice showed decreased tubular
immunotoxicity and proinflammatory mediator release. Mechanistically, use of apocynin
or phenyl boronic acid (FBA) or DMPO or miR21 antagomir inhibited leptin primedmiR21-mediated mesangial cell activation in vitro suggesting a direct role of leptinmediated NOX-2 in miR21-mediated mesangial cell activation. Finally, JAKSTAT
inhibitor completely abrogated the mesangial cell activation in leptin-primed cells
suggesting that leptin signaling in the mesangial cells depended on the JAK-STAT
pathway. Taken together the study reports a novel mechanistic pathway of leptin mediated
renal inflammation that is dependent on NOX-2-miR21 axis in ectopic manifestations
underlying NAFLD-induced co-morbidities.
3.1 INTRODUCTION:
Fatty liver is the most common cause of chronic liver injury 111). Non-alcoholic fatty liver
disease (NAFLD) is well-defined as the excessive accumulation of fat (>5%) in the liver
without excessive consumption of alcohol and often considered as a benign disease in the
background of altered mediators of metabolic syndrome and pro-inflammatory immune
response (111,112). If untreated, NAFLD can progress from simple steatosis to complex
stage of nonalcoholic steatohepatitis (NASH), hepatic fibrosis and hepatocellular
carcinoma (113) following a second or multiple hits from oxidative stress, underlying low
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grade sterile inflammation or environmental factors (5). The contribution of
NAFLD/NASH in several ectopic diseases and pathological conditions such as type 2
diabetes (T2DM), cardiovascular disease (CVD), Chronic Kidney Disease (CKD) has been
discussed in previous studies (114,115). Recently, enormous interest has been generated
following multiple studies dealing with NAFLD/NASH-associated CKD. (116). We have
shown previously that acclelerated glomerular pathology follows a NASH phenotype
(117). Additionally, CKD represents a major health concern in adults over age 65 years
and it covers 25% of the western populations (118). Commonly, CKD is described as
decreased estimated glomerular filtration (eGFR) and/or increased proteinuria. At the
advanced stage, CKD patients develop the end-stage renal disease because of the high risk
of cardiovascular disease. Further, NAFLD is characterized by metabolic disturbances
including insulin resistance and leptin resistance and inflammatory response in the liver.
Leptin is a cytokine mainly produced by adipocytes and plays a proinflammatory role in
the liver (119.120). The primary function of leptin is to regulate satiety and control fat
metabolism (121). The increased levels of circulatory leptin (hyperleptinemia) found in
NAFLD can influence inflammatory response in an ectopic organ such as the kidney in
addition to other comorbidities already reported in the clinics (116, 122, 123]. In the
advanced stage of NAFLD/NASH, the common factor associated with NAFLD/NASH
progression such as oxidative stress, activations of JAK/STAT, TGF-β signaling, reninangiotensin system, TLR4 pathways and release of inflammatory cytokine may strongly
associate with kidney disease (117, 74-103). We and others have previously shown that
oxidative stress is the key regulator in NASH via second hit/multiple hit theory (119, 125127]. The redox stress generated by xenobiotic enzyme Cytochrome p450 2E1 (CYP2E1)
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via a free-radical mechanism generates reactive oxygen species (ROS) and reactive
nitrative species (RNS) in the liver (128). The oxidative stress resulted from reductive
metabolism of CYP2E1, can accelerate metabolic disturbances, leptin release and trigger
host innate immune response (ref). The cascade of redox signaling, presence of damage
associated molecular patterns (DAMPS) and presence of high circulatory leptin can
stimulate NADPH oxidase system in distal organs such as the kidney (119, 39, 129). The
NADPH oxidase (NOX) is commonly expressed in both phagocytic and non-phagocytic
cells (130). In Kidney, NADPH oxidases have divergent localization in the renal cells
which include mesangial cells, tubular cells endothelial cells and podocytes (131). Though
NOX4 is predominant in the kidney, NOX-2 is primarily expressed on mesangial cells and
podocytes, but their functional significance remains unclear (132). The NOX2 is primarily
composed of several subunits mainly GP91 phox (membrane subunits) and P47 phox
(cytosolic subunit) (130). When the proper signal stimulates NOX2 activation it leads to
the alignment of the cytosolic subunit (p47phox) to the membrane subunit (gp91phox).
Localized NOX2 is involved in superoxide generation and can lead to the increased burden
of oxidative stress and kidney inflammation (133). NOX2 has also been shown to activate
the TLR4 system which includes recruitment of TLR4 into lipid rafts and further receptor
dimerization and activation in several inflammatory responses (126, 134). Previously, we
and others have shown that NOX2, when stimulated by leptin, can generate peroxinitrite
in different disease model such as intestinal inflammation or inflammatory bowel disease
(IBD), liver inflammation in NASH, (124, 129, 135). Since evidence is scarce to explain
the specific NOX2 mediator involved in TLR4 activation in the mesangial cell, we chose
to investigate the role of peroxinitrite in NOX2 mediated TLR4 activation in kidney

48

inflammation. Recently, it has been shown that the highly reactive oxidant, peroxinitrite
mediates glomerular lesion by JAK/STAT signaling pathway (136). In our previous
studies, Leptin has been shown to stimulate epigenetic regulation and microRNA induction
in experimental NASH (137). The Non-coding microRNA (miR) negatively regulates
target protein by degrading mRNA (transcript degradation) and/or interfering in the process
of protein translation. miR21 has been significantly upregulated in several inflammatory
responses such as experimental NASH, hematopoietic cells, and allergic response (137139). In both liver and kidney injury, miR21 plays a key role in fibroblast activation and is
a prominent regulatory factor in Smad7/TGF-beta signaling (74, 140, 141). Considering
these facts, in the present study, we hypothesize that increased circulatory leptin due to
CYP2E1-induced oxidative stress in NAFLD activates mesangial cells and renal
inflammatory response. Further leptin, acting via JAK/STAT-mediated NOX2 activation
in the glomerulus induces miR21mediated proinflammatory pathway that affects
progression of kidney disease. This present study uses an established invivo mouse model
of CYP2E1-primed NASH, leptin knockout (KO) mice, p47 phox KO mice and miR21 KO
mice along with kidney mesangial cells to show the mechanism of NOX2-initiated renal
inflammation.
3.2 MATERIALS AND METHODS
Bromodichloromethane (BDCM), a known substrate for CYP2E1-mediated oxidative
stress in the liver and corn oil were purchased from Sigma-Aldrich (St. Louis, MO). Anti–
αSMA, anti–IL1β, anti–TNFα, anti-TLR4, Anti-3-Nitrotyrosine (3NT), anti P47phox and
anti GP91phox primary antibodies were purchased from Abcam (Cambridge, MA).
Species-specific biotinylated conjugated secondary antibody and streptavidin -HRP were
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purchased from Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA). Wildtype and gene-specific KO mice were purchased from The Jackson Laboratories (Bar
Harbor, ME) and Taconic Farms Inc. (Hudson, New York). Fluorescence-conjugated
(Alexa fluor) secondary antibodies and ProLong Gold antifade mounting media with DAPI
were bought from Thermo Fisher Scientific (Waltham, MA) Animal diets were purchased
from Research Diets (New Brunswick, NJ). All other chemicals were purchased from
Sigma Aldrich unless otherwise specified. Paraffinized tissue sections on slides were done
by IRF, University of South Carolina School of Medicine and AML laboratories
(Baltimore, MD).
Cell culture: Kidney Mesangial cell line (CRL-1927) was purchased from ATCC
(Manassas, VA) and maintained in Dulbecco's modified eagles medium, Corning
(Tewksbury, MA). The media was supplemented with 10% fetal bovine serum, Atlanta
Biologicals (Norcross, GA), 2mM glutamine, 100U/ml Penicillin, and 100ug/ml
streptomycin; Gibco (Grand Island, NY) at 37°C in a humidified atmosphere of 5% CO2.
Cells had been serum-starved (DMEM with 0.25% FBS) overnight before cell were given
any treatment. The cells were then treated with Leptin 100ng/ml, Biovision (Milpitas, CA),
mir21 inhibitor 20 µM (Qiagen, Valencia, CA), JAK-STAT inhibitor (Ruxolitinib) 10 µM
(Invivogen, San Diego, CA), separately or in combination with Leptin and Apocynin 100
µM an inhibitor of NADPH oxidase activity. Phenyl Boronic Acid (FBA) 100 µM was
used as a scavenger for Peroxynitrite. Spin trap DMPO 100 µM (5,5 dimethyl-1- Pyrroline
N- oxide) (Alexis biochemical San Diego, CA) was used to scavenge free radicals via spin
trapping. Cells were lysed in Trizol, Invitrogen (Grand Island, NY) for mRNA extraction
or plated on coverslips MatTek Corp, (Ashland, MA) on each well of 6 well plates
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maintaining the aforementioned conditions and the adhered cells on coverslips were used
for immune-luorescence staining after completion of the treatment.
Mouse Models: All mice were housed one per cage at 23-24°C with a 12-h/12-h light/dark
cycle with ab-libitum access to food and water. The mice had been treated in strict
accordance with the NIH guideline for Humane Care and Use of Laboratory Animals and
local IACUC standards. All experiments have been approved by the University of South
Carolina at Columbia. Pathogen-free, adult male, C57BL/6J background mice were used
as wild-type mice for nonalcoholic fatty liver disease (NAFLD) model. These mice and
mice that contained the disrupted ob/ob gene (B6.V Lepob/J) (Jackson Laboratories)
(Leptin KO), miRNA21 gene (B6;129S6-Mir21atm1Yoli/J) and P47phox gene (alias
Ncf1) (KO; B6.129S2-Ncf1tm1shl N14; Taconic, Cranbury, NJ) were fed a high fat diet
(60% kcal) from 6 weeks until 16 weeks. After the completion of animal xperiments, mice
of all study groups were sacrificed. Immediately after anesthesia, blood from the mice was
drawn using cardiac puncture to collect serum for the experiments. The mice kidneys were
removed right after terminal surgery and dissected out and were fixed by using 10%
formalin.
Induction of CYP2E1-mediated redox stress in underlying NAFLD: We and others
have shown previously that CYP2E1-mediated redox stress is a determining factor for
progressive disease development in NAFLD. The high-fat diet fed wild-type mice
(NAFLD model) and high-fat diet fed gene knockout mice at 16 weeks were administered
BDCM (1mmol/kg, diluted in corn oil) via intraperitoneal route, twice a week for 4 weeks
to estimate the effects of chronic CYP2E1-mediated redox stress. A group of high-fat diet
fed mice (NAFLD) that had simple steatosis and were not injected with BDCM and served
51

as a non-redox primed control against high-fat diet fed wild-type mice injected with BDCM
(NAFLD+BDCM).
Immunohistochemistry: The kidneys were collected from each mouse and fixed in 10%
neutral buffered formalin (Sigma Aldrich, Missouri, USA) and paraffin embedded. These
formalin-fixed, paraffin embedded tissues were cut in 5μm thick sections. These sections
were deparaffinized using a standard protocol. Briefly, sections were put in xylene twice
for 3 min, then with xylene:ethanol (1:1) for 3 minutes, and rehydrated via a series of
ethanol (twice with 100%, 95%, 70%, 50%) 3 minutes each, twice with distilled water, and
finally rinsed twice with PBS (Sigma-Aldrich). Epitope retrieval of the sections was
completed using epitope retrieval solution and steamer (IHC-World, Woodstock, MD) for
45 minutes. 3%H202 was used for 10 minutes to block the endogenous peroxidases. The
primary antibodies like anti-αSMA, anti–IL1β, anti–TNFα, anti-TLR4 (Abcam,
Cambridge, MA) were used overnight in recommended dilutions. Species-specific
biotinylated conjugated secondary antibody and streptavidin conjugated with HRP were
used to perform antigen-specific immunohistochemistry following manufacturer’s
protocols. 3,3’ Diaminobenzidine (Sigma-Aldrich, St.Louis, MO) was used as a
chromogenic substrate. Kidney sections were counter-stained with Mayer’s hematoxylin
(Sigma-Aldrich). Phosphate buffer saline was used for washing three times between the
steps. Sections were finally mounted in Simpo mount (GBI Laboratories, Mukilteo, WA)
and observed under a 20x and 60x objectives using an Olympus BX51 microscope
(Olympus, America). Morphometric analysis was done using CellSens Software from
Olympus America (Center Valley, PA).
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Immunofluorescence: For tissue: Formalin-fixed, paraffin-embedded tissues sections
were deparaffinized using a standard protocol. Epitope retrieval of the deparaffinized
sections was completed using epitope retrieval solution and steamer (IHC-World,
Woodstock, MD) following the manufacturer’s instructions. The primary antibody 3NT
(Abcam, Cambridge, MA) and anti-gp-91phox, anti-p47phox (purchased from Santa Cruz
Biotechnology, Santa Cruz, CA) dual labeling were used at the recommended dilution.
Species-specific anti-IgG secondary antibodies conjugated with Alexa Fluor 633
(Invitrogen, California, USA) was used against anit-3NT and anti-gp-91phox, and Alexa
Fluor 488 (Invitrogen) was used against anti-P-47phox. The sections were mounted in a
ProLong gold antifade reagent with DAPI (Life technologies, EU, OR). Lastly, images
were taken under 40X objectives using Olympus BX51 microscope.
Cultured cells: After completion of the treatments of the aforementioned cell culture
section, cells attached on coverslips were fixed with 10% neutral buffered saline. After the
cells were washed with PBS containing 0.1% Triton X (Sigma), they were blocked with
3% BSA, 0.2% Tween (Fisher), 10% FBS in PBS. Cells were incubated with primary
antibodies anti-β Actin (Abcam) and anti-3NT (Abcam), for immunofluorescence duallabeling staining, followed by species-specific Alexa Fluor 488 was used against anti- βActin and Alexa Fluor 633(described above) was used against anti- 3NT. The stained cells
attached on the coverslips were mounted on slides with ProLong Gold antifade reagent
with DAPI (Life Technologies) and viewed under 40X objectives with an Olympus BX51
microscope.
Quantitative Real-Time Polymerase Chain Reaction: Gene expression levels in kidney
tissue samples and Mesangial cells were measured by two-step qRT-PCR. Total RNA was
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isolated from kidney tissue and cells using TRIzol reagent (Invitrogen) according to the
manufacturer's instructions and purified with the use of RNeasy mini columns (Qiagen,
Valencia, CA). Purified RNA was converted to cDNA using iScript cDNA synthesis kit
(Bio-Rad) following the manufacturer's standard protocol. qRT-PCR was performed with
the gene-specific primers using SsoAdvanced SYBR Green Supermix (Bio-Rad) and
CFX96 thermal cycler (Bio-Rad). Threshold Cycle (Ct) values for the selected genes were
normalized against 18S (internal control) in the same sample. The relative fold change was
calculated by the 2−ΔΔCt method. The sequences for the mouse-specific primers used for
real-time PCR are provided in table-2.
Table 3.1: Table showing the primer sequences for the different targets used in this study.
Gene

Sense

Antisense

IL-1β

CCTCGGCCAAGACAGGTC

TGCCCATCAGAGGCAAGGAGGA

GC
TNFα

CAACGCCCTCCTGGCCAAC TCGGGGCAGCCTTGTCCCTT
G

IFNγ

TGCGGGGTTGTATCTGGGG GCGCTGGCCCGGAGTGTAG
GT

α-SMA

GGAGAAGCCCAGCCAGTC

ACCATTGTCGCACACCAGGGC

GC
CD4

CACACACCTGTGCAAGAA
GC
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GCGTCTTCCCTTGAGTGACA

CD8

GCCCTTCTGCTGTCCTTGA

TAGTTGTAGCTTCCTGGCGG

T
FasL

GCAGCAGCCCATGAATTA

AGATGAAGTGGCACTGCTGTCT

CC

AC

miR21 expression levels in kidney tissues: Total miRNA was isolated from cells grown in
a monolayer by homogenization in Qiazol reagent (Qiagen) following the manufacturer's
instructions. The purification was done by using miRNeasy mini kit (Qiagen). Purified
miRNA (1,000 ng) was converted to cDNA using miScript cDNA synthesis kit (Qiagen)
following the manufacturer's protocol. qRT-PCR was performed with miRNA-21 specific
primers (Qiagen) using miScript SYBR Green PCR master mix (Qiagen) and CFX96
thermal cycler (Bio-Rad). Ct values for the selected gene were normalized against RNU62 (internal miR expression control) values in the same sample.
Western blot: Western blot for serum leptin was performed by using the standard protocol
as described by Seth et.al. 2017 (27913210). Briefly, 20 µg of denatured serum protein
resolved on novex 4–12% bis-tris gradient gel. Resolved protein bands were transferred to
nitrocellulose membrane using Trans-Blot Turbo transfer system. Further, blots were
blocked with 5% non-fat milk solution for 1 h and then incubated with antileptin antibody
for overnight at 4 °C. Species-specific anti-IgG secondary antibody conjugated with HRP
was used to tag primary antibody. ECL western blotting substrate was used to develop the
blot. Finally, the blot was imaged using G:Box Chemi XX6 and subjected to densitometry
analysis using Image J software.
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Statistical Analyses: The statistical analysis was completed by analysis of variance
(ANOVA) followed by Bonferroni post-hoc correction for intergroup comparisons
*p<0.05 is considered statistically significant.
3.3 RESULTS:
Increased circulatory leptin in NASH causes mesangial cell activation in Kidney.
We have shown previously that NASH in an underlying condition of obesity causes an
increase in hepatic CYP2E1 activity with concomitant free radical damage to lipids and
proteins (128). The adipokine, leptin is mainly produced by adipocytes in obesity and poses
inflammatory response in the liver. In CYP2E1 priming progressive NASH, BDCM
(Bromodichloromethane, or xenobiotics) act as a second hit and causes liver injury and
activation of Hepatic stellate cells (120, 35). Hepatocytes and Hepatic stellate cells produce
endogenous leptin and further causes increase in circlatory leptin and leptin resistance (120,
39). Our results in this study also showed that serum leptin was significantly increased in
BDCM exposed group (NAFLD+BDCM) as compared to NAFLD alone group (control)
(Fig. 1A, B) (p<0.05). In a previously published study, it has been shown that circulatory
leptin plays a significant role in CKD. To study the involvement of increased circulatory
leptin in CYP2E1-primed NAFLD in progression of ectopic kidney disease; we tested the
immunoreactivity and localization of α-SMA, a mesangial cell activation marker. The
results showed that there was a significant increase in α-SMA immunoreactivity in
glomerular lesions of the NAFLD+BDCM group as compared to NAFLD alone (Fig. 1C,
D; P <0.05). Xenobiotic metabolism mediated Mesangial cell activation was completely
diminished in Leptin KO groups (Fig. 1C, D; P <0.05). The results suggest that the
increased circulatory leptin play a crucial role in mesangial cell activation and
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inflammatory response in the kidney. Although we cannot rule out the involvement of
another kidney cell types at this stage, it appeared that mesangial cell activation and
proliferation is an extensive event in NAFLD associated renal disease.
Leptin causes NOX2 activation and increased peroxynitrite generation in kidney
Though leptin involves in the regulation of food intake and energy metabolism
hyperleptinemia found in obesity and NAFLD generates oxidative stress mediated by
NADPH oxidase activation (142). The NADPH oxidase isoform 2 (NOX2) is one of the
several isoforms of the gp91 phox catalytic subunit of NADPH oxidase (143). To see the
activation of NADPH oxidase system dual-labeled (gp91 phox-Red and p47phox-green)
immunofluorescence microscopy was carried out. The result showed that there was a
significant increase in gp91 phox-p47phox co-localization (yellow) events in the
glomerulus of BDCM exposed group as compared to NAFLD group alone (Fig.2A, B)
(p<0.05). The leptin KO mice exposed to BDCM showed decreased co-localization of both
subunits and suggested decreased NADPH oxidase activation in glomerulus in the absence
of leptin. The activation of NADPH oxidase system is further associated with higher
oxidative stress, as evident from the increased tyrosyl radical formation (3nitrotyrosine
immunoreactivity) in the glomerulus and other tubular structures (133, 119). Further, the
results showed that the mice exposed with BDCM had significantly increased 3nitrotyrosine immunoreactivity as compared to NAFLD group alone that was significantly
decreased in p47phox KO mice fed with a high fat diet exposed to BDCM (Fig 2C, D)
(p<0.05). The data suggest that higher leptin induced NOX2 assembly that was essential
for activation of NADPH oxidase system and perpetuated nitrative stress generation in the
kidney.
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Leptin-NOX2 axis causes mesangial cell activation and renal inflammation.
The role of NADPH oxidase has been demonstrated in several experimental models of
renal injury such as Diabetic nephritis (144) a hHcys model of glomerulosclerosis (145).
To study the role of leptin-induced activation of NADPH system complex and peroxynitrite
generation in mesangial cell injury, mouse kidney tissue was evaluated for α-Smooth
Muscle Actin (α-SMA) immunoreactivity by immunohistochemistry. The result showed
that mesangial cell activation marker, α-SMA was significantly increased in BDCM
exposed N AFLD group as compared with NAFLD alone group (Fig. 3A,
C)(p<0.05).P47phox KO mice group exposed with BDCM showed significantly decreased
immunoreactivity for α-SMA (Fig. 3A, C)(p<0.05). The data strongly suggested that
mesangial cell activation was dependent on oxidative stress mediated by active NADPH
oxidase assembly. The glomerular mesangial when activated imposes not only the
thickening glomerular lining but also plays a crucial role in chronic renal inflammation
(146). NADPH oxidase-mediated 3-nitrotyrosine has also been studied in several
inflammatory diseases (124, 191, 147, 148). To study the role of NOX2 mediated renal
inflammation in this study, qRTPCR, and immunoreactivity of TLR4 and inflammatory
cytokines were carried out. Results showed that TLR4 expression was significantly
increased in BDCM exposed NAFLD group (NAFLD+BDCM) as compared to NAFLD
alone group, while the P47phox KO+BDCM group showed a significantly decreased TLR4
expression (Fig 3B,D,E) (p<0.05). The qRTPCR analysis of inflammatory cytokines and
markers of proinflammatory T cell subtypes showed significantly increased expression of
IL1β, IFNγ, CD4, CD8 and TNF-α in BDCM exposed NAFLD kidney when compared
with NAFLD alone while they were significantly decreased in P47phox KO mice group
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exposed with BDCM (Fig 4A) (p<0.05). A similar data was also obtained in the glomerular
regions where immunoreactivity of IL1β and TNF-α showed a significant increase in
NAFLD mice exposed with BDCM (NAFLD+BDCM) and a parallel significant decrease
in the P47phox+BDCM group (Fig 4B-D) (p<0.05). Results also showed a significantly
increased migration of CD4+ T-cells (12 folds) in comparison to CD8+ T-Cells (2.5 folds)
in a NAFLD+BDCM group of mice as compared to NAFLD alone and significantly
decreased in P47phox KO+BDCM group suggesting a strong T cell inflammatory
phenotype (Fig 4A) (p<0.05). The above data suggest that mesangial cell activation and
inflammation in the kidney is dependent on activation of NADPH oxidase system.
Leptin-mediated increased peroxynitrite generation in mesangial cell is NOX2
dependent To study the mechanism of Leptin-induced NOX2 activation and subsequent
peroxynitrite generation in mesangial cells of the kidney, experiments were performed with
mesangial cell culture primed with adipocytokine leptin. The immunofluorescence images
(Red: 3-nitrotyrosine) of cultured mesangial cells showed that cells primed with leptin
caused a significant increase in 3-nitrotyrosine immunoreactivity when compared with
corresponding vehicle control (Fig 5A-B) (p<0.05). However, leptin primed mesangial
cells co-treated with Apocynin (NADPH oxidase nonspecific inhibitor), or DMPO (free
radical spin trap) or FBA (peroxynitrite scavenger) showed a significant decrease in 3nitrotyrosine immunoreactivity as compared to leptin-treated cells alone (Fig 5A-B)
(p<0.05). The results suggest that the leptin-mediated generation of 3 Nitrotyrosine in the
mesangial cell was NOX2 and peroxynitrite dependent. Further to explore how leptin
activates NOX2-induced peroxynitrite generation and tyrosyl radical formation, we used a
JAK- STAT inhibitor to block leptin signaling. Results showed a significant decrease in 3-
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nitrotyrosine immunoreactivity in JAK-STAT treated cells primed with leptin when
compared to cells primed with leptin alone (Fig. 6A-B) (p<0.05). The data suggested that
leptin activated NOX2 via a JAK-STAT pathway and ruled out an endogenous mesangial
specific in situ activation independent of leptin.
Leptin-NOX2-peroxynitrite-axis causes miR21 upregulation and mesangial cell
activation.
We and others have shown that miR21 plays a crucial role in modulating inflammation in
liver disease (137, 149). It has been demonstrated that the expression and function of
miR21 is regulated by NADPH oxidase-dependent reactive oxygen species in prostate
cancer (150). In Kidney, the miR21 expression is associated with renal fibrosis and
inflammation (151). To study how leptin-mediated NOX2 induction and its downstream
peroxynitrite caused miR21 upregulation, we used mesangial cell culture primed with
leptin and co-treated with Apocynin or FBA or DMPO or a widely used JAK/STAT
inhibitor. Results showed that miR21 expression in mesangial cells were significantly
increased in leptin primed cells as compared to vehicle control group alone (Fig 7A)
(p<0.05). Interestingly, miR21 expression was significantly decreased in leptin primed
mesangial cells co-treated with NADPH oxidase inhibitor (Apocynin) or free radical
scavenger (DMPO) or peroxynitrite scavenger (FBA) as compared to leptin primed
mesangial cell alone (Fig 7A) (p<0.05). To confirm the role of leptin signaling in the
increase of miR21 expression, we co-treated the leptin primed mesangial cells with
JAK/STAT inhibitor. The results showed a significant decrease in miR21 expression as
compared to leptin alone group (Fig 7A). The data suggested that upregulation of miR21
in the mesangial cell is dependent on the leptin-mediated NOX2 pathway and its
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downstream signaling mediators. Further, to explore Leptin-NOX2-peroxynitrite axis
induced miR21 as a key event in mesangial cell activation, we co-treated leptin primed
mesangial cells with miR21 inhibitor or JAK/STAT inhibitor and tested for mesangial cell
activation by qRTPCR for α-SMA, an activation marker. Results showed a significant
decrease in α-SMA mRNA expression in miR21 inhibitor or JAK/STAT inhibitor cotreated
group as compared to Leptin primed mesangial cells (Fig. 7B, C)(p<0.05). In parallel, to
prove the results obtained from in vitro mesangial cell culture, BDCM was given
intraperitoneally to miR21 KO – NAFLD mice. The invivo results showed that miR21 KO
mice have significantly decreased α-SMA immunoreactivity as compared to a
NAFLD+BDCM group of mice (Fig 7D, E) (p<0.05). Similarly, mRNA expression of
αSMA in miR21 KO treated with BDCM was significantly decreased as compared to
NAFLD+BDCM mice or NAFLD mice alone (Fig. 7F) (p<0.05). Taken together, Invitro
and invivo results suggested that leptin-induced NOX2-peroxynitrite signaling causes
mesangial cell activation via an increased expression of miR21.
Leptin-NOX2-peroxynitrite-axis

induced

miR21

upregulation

causes

an

inflammatory response in the kidney.
MiR21 induction has been reported in several inflammatory diseases (137, 149). To study
the role of elevated miR21 in the kidney due to NOX2 induced by leptin, we treated miR21
KO mice with BDCM and observed the inflammatory markers typical to
glomerulonephritis and tubular disease. Results showed that the mRNA expression of proinflammatory cytokines IL-1β, TNF-α and IFN-γ were significantly elevated in BDCM
treated NAFLD mice (NAFLD+BDCM) as compared with NAFLD group alone (Fig. 8A)
(p<0.05). However, miR21 gene deleted mice treated with BDCM (miR21 KO+BDCM)
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showed a significant decrease in mRNA expression of these proinflammatory markers
when compared with a NAFLD+BDCM group of mice (Fig. 8A) (p<0.05). Also, the
protein levels of IL-1β showed significantly increased IL-1β immunoreactivity in BDCM
treated NAFLD mice (NAFLD+BDCM) as compared with NAFLD mice alone (Fig.8B,
C) (p<0.05). However, miR21 KO treated with BDCM showed significantly decreased IL1β immunoreactivity as compared with a NAFLD+BDCM group of mice (Fig.8B, C)
(p<0.05). The results suggested that miR21 plays a crucial role in kidney inflammation
especially related to glomerulonephritis.
3.4 DISCUSSION
There is mounting evidence in the clinics of a higher prevalence of chronic kidney diseases
in patients with advance stages of NASH (152, 90). With NAFLD/NASH being considered
a global pandemic, it is important that increased research emphasis be provided for
understanding of the pathology and ectopic mediators of NAFLD/NASH. Our present
report builds logically from our previous findings that showed a strong link to glomerular
inflammation in murine models of NAFLD (117). We and others have shown that high
circulatory leptin in NASH is proinflammatory and generates a high flux of reactive oxygen
species generation primarily through the activation of NOX2 in the liver (119). In the
present study we argued that high circulatory leptin that is a result of either leptin resistance
or increased hepatic production of the protein might be a causal link to the inflammation
observed in distal organ systems including the cardiac and renal organs. We found that
NAFLD-induced

high

leptin

was

responsible

for

increased

mesangial

cell

immunoreactivity for α-SMA, a marker for its activation. Interestingly both acute and
chronic kidney disease show increased activation of the mesangial cells that lead to
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increased inflammation by release of proinflammatory cytokines and concomitant increase
in TGF-beta signaling (117, 153). Results in the present study also showed that absence of
leptin abrogated the mesangial cell activation while deletion of p47phox in mice produced
the same result. The activation of NOX2 in mesangial cells responsible for oxidative stress
was significantly high in mice that had advance form of NAFLD when primed with a
CYP2E1 ligand, while the response was blunted in the absence of leptin. It appears from
the data that higher circulatory leptin induced an ectopic NADPH oxidase activation in the
distal mesangial cells. The NOX2 activation caused a significant increase in
proinflammatory mediators like IL1β, TNF α and IFN-γ in addition to higher CD4 and
CD8 expression suggesting an elicitation of a strong innate and adaptive immune response
in the kidney. However, the use of whole body systemic knockouts for leptin and p47 phox,
do not clearly support the cause that underlines the role of leptin and NOX2 in the kidney
alone. Underlying adiposity that is a hallmark of the present model can also produce low
lying systemic inflammation that can augment mesangial cell NOX2 activation. The use of
kidney specific deletion of NOX2 might have answered the above limitation of the study.
Interestingly our results using a mesangial cell line that is primed with identical
concentrations of leptin that was found in the systemic circulation caused a similar NOX2
activation and tyrosine nitration suggesting that the lack of kidney specific knockout did
not alter our interpretations of an endocrine role of leptin in NAFLD/NASH. Our in vitro
results further showed that a higher NOX2 activation led to an increased peroxynitrite
generation that was abrogated by the use of both DMPO, a spin trap and FBA, a specific
peroxynitrite scavenger. The results suggested that higher NOX2 activation was able to
produce sufficient localized peroxynitrite generation that has been found to initiate redox

63

signaling primarily through activation of the AKT pathway or rapidly nitrating enzymes
like CPB1 thus rendering them inactive and allowing uninterrupted inflammation, though
such an interpretation is speculative at this time (133). Since glomerular inflammation has
been shown to be associated with a higher miR21 levels, a mediator of inflammation, we
sought to study the role of NOX2-derived peroxynitrite in modulating the levels of miR21
(154). Results showed that peroxynitrite was instrumental in increasing miR21 levels in
the mesangial cells since use of FBA decreased its levels. However, it remains to be seen
whether peroxynitrite might have directly induced miR21 levels or it has done so by
increasing TLR4 activation. The chances of the latter in the present model is more likely
since use of p47phox KO mice decreased kidney TLR4 expression and use of FBA
decreased TLR4 expression (data not shown) with a parallel decrease in miR21. We have
shown previously that NOX2-derived peroxynitrite was instrumental in trafficking TLR4
to lipid rafts, an essential mechanistic event in TLR4 activation (124). Thus, increased
TLR4 expression coupled with its activation might be a likely cause of increased miR21
levels in the mesangial cells. This result is supported by the fact that miR21 coupled with
other miRs are induced by TLR4 dependent mechanisms (138).
Having observed an increase in miR21 levels in the mesangial cells primarily
driven by leptin induced NOX2, we chose to study the effect of the inducible miR21 on
the mesangial cell activation, release of proinflammatory meditators and glomerular
inflammation. Results showed a significant increase in mesangial cell mediated expression
of α-SMA, that was inhibitable following the use of miR21 specific antagomir. Further, the
data was supported by the corresponding use of miR21 KO mice that showed decreased
mesangial cell activation and expression of proininflammatory mediators in the NAFLD-
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Kidney tissue suggesting that the above cited miR was downstream of a NOX2-mediated
peroxynitrite surge essentially caused by higher circulating leptin.
Thus, in summary the present study addresses a novel and timely issue of NAFLDinduced ectopic manifestation of kidney disease and underlines a mechanistic role of
NOX2 induced redox signaling that can be a future basis for therapeutic intervention in
such pathology. The above mechanism can also be used to understand the pathways that
exist in other comorbidities of NAFLD such as cardiovascular and neuronal complications.
Further, use of miR21 as a clinical biomarker for kidney complications in NAFLD can be
strengthened by the observations of this study and use of miR21 antagomirs can be used as
future therapeutic tools.
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Figure 3.1 Increased circulatory leptin causes mesangial cell activation in the NAFLDKidney. A. Western blot analysis for serum leptin in NAFLD group and NAFLD group
treated with BDCM. B. The morphometric analysis of the western blot normalized with
ponceau S band. C. Immunoreactivity of alpha-smooth muscle actin (α- SMA, a marker
for mesangial cell activation) as shown by immunohistochemistry in kidney slices from
mice fed with high fat diet (60% kcal fat) NAFLD serve as a control, NAFLD mice exposed
to BDCM (NAFLD+BDCM), Leptin gene-deficient (Leptin KO) mice fed with high fat
diet and exposed to BDCM. Images were taken at 60X. D. Morphometric analysis of αSMA immunoreactivity (mean data measured as arbitrary light units from three separate
microscopic fields were plotted on y-axis) in NAFLD, NAFLD+BDCM, and Leptin KO+
BDCM groups (*P<0.05).
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Figure 3.2 Leptin induces renal NOX2 activation and subsequent tyrosyl radical formation.
A. Colocalization of GP91/ P47phox as shown by immunofluorescence imaging in kidney
slices from mice fed with high- fat diet (NAFLD), NAFLD mice exposed to BDCM, and
Leptin gene-deficient mice fed with high-fat diet and exposed to BDCM (Leptin KO +
BDCM). B Immunoreactivity of 3-nitrotyrosine (3NT) as shown by immunofluorescence
imaging in kidney slices from mice fed with high- fat diet (NAFLD), NAFLD mice
exposed to BDCM, and P47phox gene-deficient mice fed with high-fat diet and exposed
to BDCM (P47phox KO + BDCM). C Morphometric analysis of GP91/P47phox
colocalized in NAFLD, NAFLD+BDCM, Leptin KO+BDCM group of mice. All
immunofluorescent Images were taken at 40X and mean colocalization events were
measured as arbitrary light units from three separate microscopic fields (plotted on y-axis)
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(*P<0.05). D Morphometric analysis of 3NT immunoreactivity in NAFLD,
NAFLD+BDCM, P47phox KO+BDCM group of mice. Morphometric analysis was
performed as mean data (immunoreactivity measured as arbitrary light units) from three
separate microscopic fields (plotted on y-axis) (*P<0.05).

Figure 3.3 NOX2 activation leads to mesangial cell priming and increased TLR4
expression in the renal tissue. A and B Immunoreactivity of α-SMA and TLR4 respectively
as shown by immunohistochemistry in kidney slices from mice fed with high- fat diet
(NAFLD), NAFLD mice exposed to BDCM, and P47phox gene-deficient mice fed with
high-fat diet and exposed to BDCM (P47phox KO + BDCM). All immunohistochemistry
Images were taken at 60X. C Morphometric analysis of α-SMA immunoreactivity in
NAFLD, NAFLD+BDCM, P47phox KO+BDCM group of mice. D Morphometric analysis
of TLR4 immunoreactivity in NAFLD, NAFLD+BDCM, P47phox KO+BDCM group of
mice. All morphometric analysis was carried out as mean data from three separate
microscopic fields. (plotted on y-axis) in NAFLD, NAFLD+BDCM, P47phox KO+BDCM
group of mice. E. mRNA expression of TLR4 gene in kidney tissue of NAFLD,
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NAFLD+BDCM, P47phox KO+BDCM group of mice fed with high-fat diet. mRNA
expression had been appraised by quantitative real-time PCR (qRTPCR) and expressions
were normalized against NAFLD group (*P<0.05).

Figure 3.4 NOX2 activation leads to a surge of proinflammatory mediators in NAFLDKidney A. mRNA expression analysis of IL-1β, IFN-γ, TNF-α, CD4, and CD8 genes in
kidney tissue of NAFLD, NAFLD+BDCM, and P47phox KO mice fed with high-fat diet.
All mRNA expression had been assessed by quantitative real-time PCR (qRTPCR) and
expressions were normalized against NAFLD group (*P<0.05). B Kidney tissue slices
were probed for IL-1β and TNF-α immunoreactivity in NAFLD group (serve as a control),
NAFLD+BDCM, and P47phox mice group. C, D Morphometric analysis of IL-1β and
TNF-α immunoreactivity as observed in the region of interest (ROI) (*P<0.05).
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Figure 3.5 NOX2-derived peroxynitrite causes generation of tyrosyl radicals in mesangial
cells. A. Immunoreactivity of 3NT as shown by Immunofluorescence microscopy in kidney
mesangial cell line(CRL-1927). Mesangial cells were treated with media only served as
control and other sets of Mesangial cells were treated with leptin, leptin+ Apocynin, leptin+
DMPO, leptin+ FBA. B Morphometric analysis of 3NT immunoreactivity in control,
leptin, leptin+ Apocynin, leptin+ DMPO, leptin+ FBA groups of mesangial cells
(*P<0.05).
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Figure 3.6 Leptin signaling in mesangial cells induce tyrosyl radicals that is peroxynitrite
dependent A. Immunoreactivity of 3NT as shown by Immunofluorescence microscopy in
control, leptin, leptin+ JAK/STAT inhibitor kidney mesangial cell line(CRL-1927) group.
Nuclear staining was appeared by DAPI (blue) stain. 3NT immunoreactivity was
functioned by Immunofluorescence microscopy after the protein had been labeled with the
red fluorescent secondary antibody. Images were taken at 40X. B Morphologic analysis of
3NT immunoreactivity in control, leptin, leptin
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Figure 3.7 Leptin-NOX2-Peroxynitrite axis causes mesangial cell activation via miR21. A.
mRNA expression analysis of miRNA 21 (miR21) gene expression in control (mesangial
cells line (CRL-1927) treated with media only served as control), mesangial cells treated
with leptin (leptin), mesangial cells groups were coexposed with leptin and Apocynin
(leptin+ Apocynin), leptin and FBA (leptin+ FBA), leptin and DMPO (leptin+ DMPO),
and leptin and JAK/ STAT inhibitor (Leptin+ JAK/STAT inh). miRNA expression had
been assessed by quantitative real-time PCR (qRTPCR) and expressions were normalized
against control (*P<0.05). B. mRNA expression analysis of αSMA genes in kidney
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mesangial cells of control, Leptin, Leptin+ miRNA 21 inhibitor (miR21 inhibitor). mRNA
expression has been assessed by quantitative real-time PCR (qRTPCR) and expressions
were normalized against mesangial cell control (*P<0.05). C Immunoreactivity of α-SMA
as observed by immunohistochemistry in kidney slices from (NAFLD), NAFLD mice
exposed to BDCM, and miRNA21 gene-deficient mice fed with high-fat diet and exposed
to BDCM (miR21 KO + BDCM). All immunohistochemistry Images were taken at 60X.
D Morphometric analysis of α-SMA immunoreactivity in NAFLD, NAFLD+BDCM,
mir21 KO+BDCM group of mice. All morphometric analysis was performed as mean data
from three separate microscopic fields (designed on y-axis) in NAFLD, NAFLD+BDCM,
miR21 KO+BDCM group of mice(*P<0.05). E. mRNA expression analysis of α-SMA
gene in kidney tissue of NAFLD, NAFLD+BDCM, and miR21 KO+BDCM mice. mRNA
expression has been assessed by qRTPCR and was normalized against NAFLD group
(*P<0.05).
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Figure 3.8 miR21 increase causes kidney inflammation. A mRNA expression of IL-1β,
TNFα, and IFNγ in kidney tissue from mice fed with high-fat diet NAFLD serve as a
control, NAFLD mice exposed to BDCM (NAFLD+BDCM), miRNA 21 gene-deficient
mice exposed to BDCM (miR21 KO+BDCM) as assessed by quantitative real-time PCR,
the expressions were normalized with 18S and compared to the NAFLD group(*P<0.05).
B Immunoreactivity of IL-1β as shown by immunohistochemistry in kidney slices from. of
NAFLD, NAFLD+BDCM, and miR21 KO+BDCM group of mice Images were taken at
20X. C Morphometric analysis of IL-1β immunoreactivity in NAFLD, NAFLD+BDCM,
and miR21 KO+BDCM group of mice(*P<0.05).
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CHAPTER 4
MICROCYSTIN EXPOSURE MODULATES NOX-2-MIR21 AXIS IN
ECTOPIC GLOMERULAR TOXICITY IN UNDERLYING
NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Alhasson F, Chandrashekaran V, Dattaroy D, Seth R, Albadrani M, Scott GI,
Raychowdhury S, Nagarkatti M, Nagarkatti P, and Chatterjee S. To be submit to Journal
of Redox Biology.
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Abstract
NAFLD often results in cardiovascular, intestinal and renal complications. Previous reports
from our laboratory exhibited NAFLD induced ectopic inflammatory manifestations in the
kidney that gave rise to glomerular inflammation. Extending our studies, we hypothesized
that existing inflammatory conditions in NAFLD could make the kidneys more susceptible
to environmental toxins. Our results showed that exposure of Microcystin-LR (MC) in
NAFLD mice caused a significant increase in mesangial cell activation as evidenced by
increased a-SMA in the extracellular matrix surrounding the glomeruli. Renal tissue
surrounding the glomeruli also had increased NOX2 activation as shown by increased colocalization of p47 Phox and its membrane component gp91 that. To show whether NOX2
activation and subsequent NOX2-miR21 axis were key to microcystin exposure and
exacerbation of renal toxicity, experiments were designed in vitro with immortalized
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mesangial cells of mouse origin. The cells incubated with (a) apocynin and (b) nitrone spin
trap DMPO and (c) miR21 inhibitor showed significantly decreased a-SMA, miR21 levels
and proinflammatory cytokine release in the supernatant. In parallel, mice lacking miR21,
a proinflammatory miR, known to be activated by NOX2, when exposed to MC in NAFLD
showed decreased mesangial cell activation. Mechanistically, phenyl boronic acid
incubated cells that are exposed to MC showed significantly decreased mesangial cell
activation showing that peroxynitrite might be the major reactive species involved in
mediation the activation process, release of proinflammatory micro RNAs and cytokines
that are crucial for renal toxicity. Thus, in conclusion, MC exposure causes NOX2
activation that leads to mesangial cell activation and toxicity via release of peroxynitrite
and miR21.
4.1 INTRODUCTION:
Cyanobacteria are prokaryotic organisms found in fresh and brackish water throughout the
world. It is growing fast under special water climates with certain water nutrients like
nitrogen and phosphorus to govern phytoplankton which results in cyanobacteria blooms
(155). Each type of cyanobacteria produces a specific toxin which releases after
cyanobacteria death (156). Among all cyanotoxins, the microcystin is a very common
cyanotoxin, which is widely dispersed throughout aquatic world. The microcystin family,
has almost 90 isoforms, consists of heptapeptide (β-amino acid(ADDA), alanine (D-ala),
D- β

-methyl-isoaspartate(D-β-Me-isoAsp),

and glutamic

acid (D-glu))

(157).

Microcystin-LR is one of most potent toxins which releases from cyanobacteria and causes
different pathological conditions (158). Chronic low dosage of microcystin-LR exposure
through different routes, like drinking contaminated water, direct skin contact, or by
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inhalation can cause human health problems (159). Although the liver is a primary target
for microcystin, different organs can be impacted such as the kidneys and the gut (159,160).
Therefore, microcystin exposure links with various diseases like hepatic inflammation,
gastroenteritis, and liver and colon cancers (160,161,162). Inhibition of serine/threonine
protein phosphatases, especially protein phosphatase 1 (PP1) and protein phosphatase 2- A
(PP2A), is the most common pathway of microcystin activity inside cells (163,164,165).
Nong et al found that microcystin-LR exposure caused reactive oxygen series (ROS)
generation through cytochrome P 450 enzyme especially CyP2E1 subunit. Thereby, lipid
peroxidation, oxidative stress, and mitochondrial dysfunction can be mediated by
microcystin-LR exposure (166).
Obesity is one of the most public health problems in the world, particularly in
developed countries because of its prevalence. The consequences of obesity include
premature death, disabilities, and a high cost of health care (167). Obesity has several
medical complications, which include cardiac diseases, hypertension, and liver
abnormalities such as Nonalcoholic fatty liver disease (NAFLD) (168). NAFLD is a wide
spectrum phenomenon including a simple form called nonalcoholic fatty liver which
characterized by extra fat accumulation without cell damage, and a second form is more
progress one called Nonalcoholic steatohepatitis which is characterized by high level of
inflammation and cell abnormalities (8,169). Oxidative stress-cytochrome P 450 pathway
plays a critical role in augmented NAFL to NASH through mediation of lipid peroxidation
and NADPH oxidase activation, which lead in turn to the release of proinflammation
cytokines which cause hepatic and extrahepatic cell damage (170). We have previously
demonstrated that progressing NASH can cause ectopic glomerulonephritis via mesangial
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cells activation (171). In-Vitro mesangial cell activation has been shown high expression
of alpha smooth muscle actin (αSMA) and transforming growth factor-β (TGF-β) after
treated with 4HNE a marker of lipid peroxidation while mesangial cell proliferation can be
attenuated via cytochrome P 450 inhibition by using diallyl sulphide (DAS) (171).
NADPH oxidase is a primary source of reactive oxygen series (ROS) generation.
NOX2 has been shown highly expressed in different types of cells including mesangial
cells, smooth muscle cells, in addition to macrophages (62). NOX2 expression causes
several renal diseases and disfunctions, like ischemia-reperfusion injury (IRI) and diabetic
nephropathy (62,172). NOX2 knock out mice showed less reactivity of αSMA, HNE,
picrosirius, and αSMA – SMAD2 pathway comparing with wildtype mice suffered from
IRI in different time points. which suggested that NOX2 associated with oxidative stress
released and fibrogenesis activity (173, 174).
MicroRNAs (miRNAs) are small noncoded mRNAs that play a significant role in
regulating gene expression during post-transcription. Among all miRNAs, mir21 shows
partakes in nephritis and renal fibrosis (155). In the kidney, TGFb – SMAD2/3 signaling
pathway upregulates miR21, whilst miR21 can inhibit SMAD7 and P10 causing high
expression of TGF-b signaling. Therefore, miR21 and TGF-b are a key for renal fibrosis.
(156) The present study examined the hypothesis that microcystin exposure increases
NAFLD severity causing renal damage and glomerulonephritis through mesangial cell
activation. Mechanistically, our result from in vivo and invitro showed microcystin toxin
activated mesangial cell NOX2 mediated miR21 upregulation, resulting in fibrogenesis
markers releasing and proinflammatory cytokines releasing induce renal nephrotoxicity.
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4.2 MATERIAL AND METHODS:
Microcystin-LR was purchased from Cayman (Ann Arbor, MI). Leptin was purchased
from BioVision (Milpitas, CA). Anti-3 nitrotyrosine (3NT), anti-TGF-β, anti- GP91 phox,
anti-P47phox, and anti-αSMA primary antibodies were purchased from Abcam
(Cambridge, MA). Species-specific biotinylated conjugated secondary antibody and
streptavidin-horseradish peroxidease were purchased from Vector Laboratories
(Vectastain Elite ABC kit, Burlingame, CA). Fluorescence conjugated (Alexa fluor)
secondary antibodies and ProLong Gold antifade mounting media with DAPI were bought
from Thermo Fisher Scientific (Waltham, MA). Wild-type and gene-specific knockout
(KO) mice were purchased from The Jackson Laboratories (Bar Harbor, ME). Animal diets
were purchased from Research Diets (New Brunswick, NJ). All other chemicals were of
analytic grade and were purchased from Sigma-Aldrich unless otherwise specified.
Paraffinized tissue sections on slides were done by the Instumentation Resource Facility of
the University of South Carolina School of Medicine and AML Laboratories (Baltimore,
MD).
Animal Model: Pathogen-free, adult, male mice with C57BL/6J background (Jackson
Laboratories, Bar Harbor, ME) were used in the study. They were fed with a methionine
and choline deficient (MCD) diet, (Research diets, New Brunswich, NJ) for 8 weeks and
used as a model of nonalcoholic fatty liver disease (NAFLD). Mice kept on normal chow
diet was used as a lean model. Mice that contained the disrupted P47phox gene (B6(cg)Ncf1M1J/J(JAC004742) and disrupted miR21 gene (B6.129S6-Mir21tm1 Yoli/J) (Jackson
Laboratories, Bar Harbor, ME) were fed a methionine and choline deficient (MCD) and
treated identically to the NAFLD mouse model.All mice were housed with 1 mouse/cage
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at 23–24°C on a 12:12-h light-dark cycle with libitum access to food and water. All animals
were treated in strict accordance with the NIH Guide for the Humane Care and Use of
Laboratory Animals, and the experiments were approved by the institutional review board
at the University of South Carolina at Columbia.
Toxin model: Normal chow diet wild-type mice, methionine and choline deficient (MCD)
wild-type mice, and MCD fed gene KO mice (P47phox, miR21) were administered
microcystin-LR (10 µg/kg/day) intraperitoneally for five times a week for two weeks to
assess the effects of chronic exposure to MC-LR. A set of MCD-fed mice (NAFLD model)
were not injected with MC-LR and served as controls in this study.
Cell culture: Kidney Mesangial cell line (CRL-1927) was purchased from ATCC
(Manassas, VA) and maintained in Dulbelccos modified eagles medium, Corning
(Tewksbury, MA). The media was supplemented with 10% fetal bovine serum, Atlanta
biologicals (Norcross, GA), 2mM glutamine, 100U/ml Penicillin, and 100ug/ml
streptomycin; Gibco (Grand Island, NY) at 37°C in a humidified atmosphere of 5% CO2.
Cells were serum starved (DMEM with 0.25% FBS) overnight before cell were given any
treatment. A set of cells were treated with leptin 100ng/ml, Biovision (Milpitas, CA),
another group were treated with MC-LR (20µM) separately or combination with leptin.
Other groups of cells were then treated with leptin and MC-LR and were incubated with
Apocynin (Sigma-Aldrich) 100 µM an inhibitor of NADPH oxidase activity and thus
preventing production of superoxide, Phenyl Boronic Acid (FBA) 100 µM was used as a
scavenger for Peroxynitrite, 100 mM the spin trap 3-[[2-(Biotinamido)ethyl] dithio]
propionic Acid 4’-(Hydroxymethyl)DMPO ( Alexis biochemical, San Diego, CA), miR21
inhibitor Qiagen ( Valencia, CA). The cells were then lysed in Trizol, Invitrogen (Grand
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Island, NY) for mRNA extraction or plated on coverslips MatTek Corp, (Ashland, MA)
were used for immune-fluorescence staining after completion of the treatment.
Hematoxylin and eosin staining (H&E) Formalin-fixed tissues were paraffin embedded.
Liver tissue sections were stained with hematoxylin and eosin by the Instrumentation
Resource Facility, University of South Carolina School of Medicine.
Immunohistochemistry The kidneys were collected from each animal and fixed in 10%
neutral buffered formalin (Sigma Aldrich, Missouri, USA). These formalin-fixed, paraffin
embedded tissues were cut in 5μm thick sections. These sections were deparaffinized using
a standard protocol. Briefly, sections were incubated with xylene twice for 3 min, washed
with xylene: ethanol (1:1) for 3 min, and rehydrated through a series of ethanol (twice with
100%, 95%, 70%, 50%), twice with distilled water, and finally rinsed twice with PBS
(Sigma-Aldrich). Epitope retrieval of the deparaffinized sections was performed using
epitope retrieval solution and steamer (IHC-World, Woodstock, MD) for 45 minutes.
3%H202 was used for 5 minutes to block the endogenous peroxidases. The primary
antibody for TGF-β (Abcam, Cambridge, MA) were used overnight in recommended
dilutions. Species specific biotinylated conjugated secondary antibody and streptavidin
conjugated with HRP were used to perform antigen-specific immunohistochemistry
following manufacturer’s protocols. 3, 3’ Diaminobenzidine (Sigma-Aldrich, St.Louis,
MO) was used as a chromogenic substrate. Tissue sections were counter-stained with
Mayer’s hematoxylin (Sigma-Aldrich). Phosphate buffer saline was used for washing three
times between the steps. Sections were finally mounted in Simpo mount (GBI Laboratories,
Mukilteo, WA) and observed under a 20x and 60x objectives using an Olympus BX51
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microscope (Olympus, America). Morphometric analysis was done using CellSens
Software from Olympus America (Center Valley, PA).
Immunofluorescent: IN VIVO, formalin-fixed, paraffin-embedded tissue sections were
subjected to deparaffinization according to standard instructions. Epitope retrieval of the
deparaffinized sections was done with an epitope retrieval solution and steamer (IHC
World) according to the manufacturer's protocol. The primary antibodies anti α-SMA, antigp-91phox, anti-p47phox, and anti-3NT (purchased from Santa Cruz Biotechnology, Santa
Cruz, CA, and Abcam) and used at recommended dilutions. Species-specific anti-IgG
secondary antibodies conjugated with Alexa Fluor 488 (Invitrogen) were used. The
sections were mounted in a ProLong Gold antifade reagent with DAPI (Life Technologies,
Carlsbad, CA). Images were taken under ×20 and ×60 oil objectives with an Olympus
BX51 microscope.
IN VITRO, after completion of the treatments under serum-starved conditions as
in Cell Culture, cells attached on coverslips were fixed with 10% neutral buffered saline.
After the cells were washed with PBS containing 0.1% Triton X (Sigma), they were
blocked with 3% BSA, 0.2% Tween (Fisher), 10% FBS in PBS. Cells were incubated with
primary antibodies anti- α-SMA, anti-3NT Abcam), followed by species-specific Alexa
Fluor 633 and 488. The stained cells attached on the coverslips were mounted on slides
with ProLong Gold antifade reagent with DAPI (Life Technologies) and viewed under ×40
objectives with an Olympus BX51 microscope.
Quantitative Real-Time Polymerase Chain Reaction Gene expression levels in kidney
tissue samples were grown in a monolayer by homogenization were measured by two-step
qRT-PCR. Total RNA was isolated from kidney tissue in TRIzol reagent (Invitrogen)
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according to the manufacturer's instructions and purified with the use of RNeasy mini kit
columns (Qiagen, Valencia, CA). Purified RNA was converted to cDNA using iScript
cDNA synthesis kit (Bio-Rad) following the manufacturer's standard protocol. qRT-PCR
was performed with the gene-specific primers using SsoAdvanced SYBR Green supermix
(Bio-Rad) and CFX96 thermal cycler (Bio-Rad). Threshold Cycle (Ct) values for the
selected genes were normalized against 18S (internal control) values in the same sample.
The relative fold change was calculated by the 2−ΔΔCt method. The sequences for the
mouse specific primers used for real time PCR are provided in (table 1). Total miRNA was
isolated from cells grown in a monolayer by homogenization in Qiazol reagent (Qiagen)
following the manufacturer's instructions. The purification was done by using miRNeasy
mini kit columns (Qiagen). Purified miRNA (1,000 ng) was converted to cDNA using
miScript cDNA synthesis kit (Qiagen) following the manufacturer's protocol. qRT-PCR
was performed with miRNA-specific primers (Qiagen) using miScript SYBR Green PCR
master mix (Qiagen) and CFX96 thermal cycler (Bio-Rad). Ct values for the selected gene
were normalized against RNU6-2 (internal miR expression control) values in the same
sample.
Table 4.1 Table showing the primer sequences for the different targets genes.
Target

Species

Sequence 5′-3′

MCP-1 F

Mus musculus

GTAGCAGCAGGTGAGTGGGGC

MCP-1 R

Mus musculus

CACAGTTGCCGGCTGGAGCAT

IL-1β F

Mus musculus

CCTCGGCCAAGACAGGTCGC

IL-1β R

Mus musculus

TGCCCATCAGAGGCAAGGAGGA

18SF

Mus musculus

TTCGAACGTCTGCCCTATCAA

18SR

Mus musculus

ATGGTAGGCACGGCGATA

CD68F

Mus musculus

GCTACATGGCGGTGGAGTACAA
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CD68R

Mus musculus

ATGATGAGAGGCAGCAAGATGG

Western blot SDS PAGE-Resolved protein bands were transferred to nitrocellulose
membrane using precut nitrocellulose/filter paper sandwiches (Bio-Rad Laboratories,
Hercules, CA) and Trans-Blot Turbo transfer system (Bio-Rad) in case of low molecular
weight proteins and using wet transfer module from Invitrogen for high molecular weight
proteins. Primary antibodies (Abcam) were used at recommended dilutions, and
compatible horseradish peroxidase-conjugated secondary antibodies were used. Pierce
ECL Western Blotting substrate (Thermo Fisher Scientific, Rockford, IL) was used for
detection. The blot was imaged using G:Box Chemi XX6 (Syngene imaging systems) and
subjected to densitometry analysis using Image J.
TUNEL assay Mesangial cells adhered on coverslips were used for a TUNEL assay using
an Apoptag Fluorescein in Situ Apoptosis Detection Kit (Millipore, Temecula, CA)
following the manufacturer's protocol. The cells were counterstained with propidium
iodide in antifade reagent (Millipore). Stained sections were imaged at magnification of
×40 using the Olympus BX51 microscope.
Statistical analysis All in-vivo experiments were repeated three times with 5 mice per
group (N=5; data from each group of mice was pooled). The statistical analysis was
implemented by analysis of variance (ANOVA) followed by the Bonferroni post hoc
correction for intergroup comparisons. Quantitative data from western blots as portrayed
by the relative intensity of the bands were analyzed by performing a student's t-test.
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4.3 RESULT:
Microcystin-LR exposure causes glomerular immune cellular infiltrations and
glomerular damage in present of NAFLD.
Sub-chronic dose of microcystin-LR can cause glomerular damages and infiltration of
immune cells especially eosinophils (175). To study whether NAFLD condition causes
kidney more vulnerable to microcystin exposure, renal tissue sections were imaged after
stained by Hematoxylin and Eosin (H&E). Our result showed thickness in the glomerular
wall in mice group fed with methionine and choline deficient (MCD) diet and were exposed
to microcystin-LR compared to mice fed with MCD diet without microcystin treatment
and normal chow diet mice exposing to microcystin-LR (Fig1). In addition, filtration of
immune cells and proliferation of mesangial cell is high in NAFLD group exposed to
microcystin. Microcystin-LR exposure showed significant increase of mesangial cell
proliferations in mice NAFLD, as assess in high expression of alpha smooth muscle actin
(α-SMA). The reactivity of α-SMA, which is a specific mesangial cell activation marker,
was showed high in NAFLD mice treated with microcystin compared to NAFLD mice and
lean mice exposed to microcystin (P < 0.05; Fig2, A and B). This result suggested that a
condition of NAFLD make glomeruli more susceptible to microcystin intoxication.
Microcystin potentiates NAFLD induced renal inflammation pro inflammatory
cytokines secretion in renal tissue.
We have shown previously that environmental toxin like bromodichloromethane(BDCM),
which is metabolized by cytochrome P 450 (CyP2E1), augmented NAFLD mice model to
release significant high level of cytokines in renal tissue (171). To study the effect of
microcystin-LR administration to mice models, kidney proinflammatory cytokine gene
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levels were analyzed by qRT-PCR. Results showed that mRNA expression of
proinflammatory IL-1β was significantly higher in NALFD mice treated with microcystinLR compared to NAFLD mice alone and mice were fed with normal chow diet and exposed
to microcystin (Fig3, A). Similar results were obtained for mRNA expression of MCP-1,
CD68, F4/80 were NAFLD mice treated with microcystin have significant increase of
expression compared to NAFLD mice and lean mice exposed to microcystin (Fig3; B, C,
and D). This result assumed that microcystin led to potentiate NAFLD releasing
proinflammatory cytokines in kidney, which in turn caused renal inflammation and renal
tissue damage.
Microcystin exposure activates mesangial cell NOX2 and mediates mesangial cell
NOX2 generated peroxynitrite.
NOX2 upregulation causes oxidative stress resulting in renal hypertrophy, dysregulate in
renal function, inflammation, and fibrosis (176). To prove the role of microcystin in
induction of NADPH 2 oxidase (NOX2) in progressive NAFLD, we studied the membrane
association

of

NOX2

two

subunits

(P47phox

and

GP91phox)

by

using

immunofluorescence microscopy in mice tissue samples. Results were analyzed regarding
to the number of colocalization/overlay events (shown by yellow). Results showed that the
NAFLD + microcystin-LR group had a significant increase in the colocalization events
compared with the NAFLD only group (P < 0.01) (fig.4 A and B). Lean mice group treated
was treated with microcystin-LR showed less colocalization events compared with the
NAFLD+ microcystin-LR (P < 0.01) (fig.4 A and B). Furthermore, no significant change
in colocalization events was found between Lean+ microcystin-LR and NAFLD only
group. The above outcomes propose that microcystin induced p47phox expression in
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NAFLD condition and assisted in the membrane association of p47phox and gp91phox that
assumes significance in causing oxidative stress and mesangial cell activation in NAFLD.
To demonstrate that mesangial cell NOX2 activation resulting in peroxynitrite generation,
experiments were performed in the NAFLD mice model. Results showed that NAFLD+
microcystin had significant increase in mesangial cell proliferation compared with NAFLD
only group, as assess in alpha smooth muscle actin reactivity (α-SMA) (P < 0.01) (fig.5 A
and B). P47phox KO mice had significant decreased in α-SMA activity compared with
NAFLD+ microcystin (P < 0.01) (fig.5 A and B). Our result also showed that 3nitrotyrosine immunoreactivity was significantly increased in the DIO + BDCM group
compared with the DIO group (P < 0.05) (Fig. 5, C and D). P47phox KO mice had
significant decreased in 3-nitrotyrosine immunoreactivity activity compared with
NAFLD+ microcystin (P < 0.05) (Fig. 5, C and D). The results suggested that microcystin
was significantly associated with an increase in 3-nitrotyrosine immunoreactivity, and
peroxynitrite might be a key performer in causing oxidative stress.
Microcystin administration upregulates Mesangial cell miR21expression.
Among all miRNAs have been identified, miR21 has been upregulated in different kidney
diseases, such as chronic kidney disease and acute kidney disease. Although miR21
expression existed in health kidney condition, high level of miR21 expression was
identified in kidney diseases, particularly in fibrosis (177). To prove that microcystin,
through its activation of NOX2 in vitro increases miR21 expression, experiments were
performed with mesangial cells (Fig. 6). Results showed that mesangial cell treated with
10 µM microcystin-LR and 100ng leptin (MC+Leptin) had 2.5-fold increase in miR21
expression compared to mesangial cell control (P < 0.05).
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Mesangial cells were

administrated to leptin and were treated with apocynin (MC+Leptin+Apo) or Phenyl
Boronic Acid (MC+Leptin+FBA) had significant decrease in miR21 expression compared
with MC+Leptin group (P < 0.05). Results showed that mesangial cell treated with
microcystin-LR had 1.8- fold increase in miR21 expression compared with mesangial cell
control (P < 0.05). To prove that microcystin, through high expression of miR21 activates
mesangial cell, we performed experiments with NAFLD mice kidney tissues. Results
showed that NAFLD+ microcystin had a significant increase in α-SMA expression, as
shown in immunofluorescent microscopy (2.7-fold increases) compared to NAFLD only
group (Fig.7 A and B) (P < 0.05). miR21 KO mice treated with microcystin (miR21 KO +
MC) had a significant decrease in α-SAM expression compared to NAFLD+MC mice
group (P < 0.05).
Next, we explored the role of microcystin mediated miR21 upregulate in mesangial
cells by determined immunoreactivity of α-SMA in mesangial cells. The results showed
that mesangial cells treated with leptin and microcystin (leptin+MC) had a significant
increase in α-SMA compared to mesangial cell control (Fig. 7. C and D) (P < 0.05).
Furthermore, mesangial cells incubated with leptin and microcystin and treated with
Apocynin

(leptin+MC+Apo),

FBA

(leptin+MC+FBA),

or

miR21

inhibitor

(leptin+MC+mir21 inh.) had a significant decrease in α-SMA immunoreactivity compared
to leptin+MC group (Fig. 7. C and D) (P < 0.05). The above results show that mesangial
cell proliferation is depends on miR21 upregulation. Inhibition of miR21 attenuates
mesangial cell activation and reduce inflammation cytokines releasing.
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Peroxynitrite- miR21 axis drives mesangial cell activation and death.
Recent study from our laboratory has shown that NADPH oxidase activation consequence
in peroxynitrite generation and resulting in cascade of events, such as NF-κB activation
(16). To support that NOX2 mediates peroxynitrite generation resulting in mesangial cell
activation and to find the link between peroxynitrite generation and miR21, we preformed
experiment in mesangial cell line. Result showed that mesangial cell treated with leptin
and microcystin (leptin+MC) had a significant increase in 3 nitro tyrosine (3NT) almost
1.8-fold increases compared to control mesangial cell group. (Fig. 8.A and B) (P < 0.05).
Mesangial cells were treated with leptin and microcystin and were incubated with
Apocynin

(Leptin+MC+Apo),

FBA

(Leptin+MC+FBA),

or

miR21

inhibitor

(Leptin+MC+miR21 inh.) had a significant decrease in peroxynitrite formation compared
with Leptin+MC mesangial cell group, as assess in 3NT immunoreactivity (P < 0.05).
While ROS activation and peroxynitrite generation are consequence of
microcystin-LR exposure, apoptosis is another consequence of MC-LR exposure in renal
kidney cell line (178). One possible mechanistic pathway can be through endoplasmic
reticular damages (179). To observe that microcystin caused cell death, experiments were
performed in mesangial cell line. Results showed that leptin+MC group had a significant
increase in number of apoptotic cells (1.5- fold increased) compared with mesnagial cells
served as a control. (Fig. 8.C and D) (P < 0.05). Leptin+MC+Apo, Leptin+MC+FBA, and
Leptin+MC+miR21 inh had a significant decrease in apoptotic cell number compared with
leptin+MC group (Fig. 8.C and D) (P < 0.05). The results above suggest that microcystinLR augmented NAFLD renal immunotoxicity through peroxynitrite – miR21 axis, as
assess in the 3NT immunoreactivity which blocked by miR21 inhibitor. Additionally,
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microcystin- LR causes cell death in mesangial cell in present of NAFLD, as observe in
apoptotic cell percentage by using Tunel assay.
Microcystin-LR mediated NOX2 activation and corresponding induction of miR21 in
NAFLD are crucial for TGF-β signaling pathway.Our laboratory has been shown
previously that NADPH oxidase activation and its subsequence of miR21 upregulation are
necessary to TGF-β signaling pathway which in turn response on fibrogensis (74). To
support that microcystin through NOX2- mir21 axis causes TGF-β signaling pathway
upregulation, experiments were performed in NAFLD mice model. Results showed that
kidney tissue slices from NAFLD+MC group had a significant increase in TGF-β
immunoreactivity (as showed in immunohistochemistry) compared with NAFLD only
group (Fig. 9.A and B) (P < 0.05). On the other hand, miR21 KO mice (miR21KO + MC)
had a significant decrease in TGF-β. The morphometry analysis showed that miR21 KO+
MC had a double fold decrease in TGF-β immunoreactivity compared with NAFLD+MC,
while no different in TGF-β reactivity was found between miR21 KO+MC group and
NAFLD only group. (Fig9. A and B) (P < 0.05).
Post transcription of miR21 downregulates tumor suppressor PTEN both in vivo
and in vitro. Repressing PETN and SMAD-7, play a key role in TGF-β signaling pathway.
To prove that NOX2-miR21 axis represses PTEN expression level, we performed
experiments in mice model. Results showed that microcystin administration decreased the
levels of PTEN, through upregulating of miR21 in the kidney, as shown by Western blot
analysis compared with the NAFLD only (Fig. 10. A and B). The results showed also
increase the levels of PTEN in P47phox KO +MC and miR21 KO +MC mice. The results

91

suggested that microcystin-LR might have a role in increasing NOX2-miR21 axis induced
repression of PTEN, which in turn activates TGF-β.
4.4 DISCUSSION:
The present study reports the first time that chronic exposure of microcystin-LR, a
cyanobacteria heptapeptide toxin, has been shown heighten ectopic inflammation in the
kidney. Microcystin enhances nonalcoholic fatty liver disease (NAFLD) caused renal
immunotoxicity via mesangial cell activation, as indicated by an increase α-SMA
immunoreactivity (76). We also show that mesangial cell proliferation mediated by NOX2
activation and peroxynitrite generation leads to miR21 overexpression. Furthermore, using
the rodent model of NAFLD, we observed miR21 activation caused TGF-β activation and
renal inflammation.
There is increasing evidence that a condition of NAFLD, which has high risks of
progressing to NASH, cirrhosis, and hepatocellular carcinoma, can have comorbidities that
may include kidney diseases and cardiovascular complications. The multiple hit theory is
the most likely explanation for the progression of NAFLD to NASH. Oxidative stress,
inflammatory adipokines, and environmental toxins are likely the second hit to the
progression of the NAFLD condition (171). In addition, microcystin plays a critical role in
ROS generation in the animal models and in the different cell lines (180). In the present
study, we used microcystin-LR as an environmental toxin and a causative factor to lead to
activation of NOX2 in renal NAFLD condition. Interestingly, our results showed that
microcystin-LR altered the glomerular morphology by increasing wall thickness and
increased immune cell filtration as indicated in the histopathology section of the kidney.
The alteration of glomerular structure leads to mesangial cell activation and proliferation,
92

as assessed by α-SMA immunoreactivity. Consequently, a significant increase in the levels
of proinflammatory cytokines, like IL1β, MCP-1, F4/80, and CD68 has been shown
(Fig.3). Mesangial cell proliferation is always associated with lipid peroxidation which
triggers NOX2 upregulation and peroxynitrite generation (171,75). Mesangial cell
activation is decreased in P47phox KO mice. NOX2 activation, as indicated by NOX2
subunits colocalization, is decreased in P47phox KO mice. Peroxynitrite formation also
decreases in P47phox KO mice too, as assessed by 3 nitro tyrosine, a marker of
peroxynitrite-mediated nitrative stress, indicating that mesangial cell activation is
depended on the NOX2 pathway and peroxynitrite generation.
MicroRNAs (miRNAs) are small noncoding RNAs that reduce gene expression
post-transcriptionally, thereby modulating the activity of signaling pathways, including
stress responses in many physiologic and pathologic processes. Among all miRNAs,
miR21 mediates damage to the kidney via reduction of several molecular targets (181). We
found a high level of miR21 expression level in the mesangial cell exposed to microcystinLR. We also found α-SMA, a proliferative marker of mesangial cells repressed after the
cell incubated with miR21 inhibitor. Mesangial cell proliferation also downregulated in 21
KO mice treated with microcystin-LR. These results support the conclusion that miR21
plays a dynamic role in microcystin induced mesangial cell activation. Microcystin-LR
exposure triggered cell death (apoptosis) as a biochemical feature of microcystin toxicity.
Several studies have shown that microcystin onset damages mitochondria via variant
mechanisms that alters mitochondrial features resulting in ROS formation and proapoptotic cytokines releasing (55). In the present study, we identified that mesangial cells
suffered from apoptosis after microcystin exposure, and that apoptotic event was less active
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when mesangial cells were incubated with apocynin and FBA. This indicates the apoptotic
probe of microcystin-induced mesangial cell death is NOX2 dependent, as assessed by the
reduced number of positive apoptotic cells (Tunel assay) after administration of NADPH
oxidase inhibitor and a specific scavenger and blocking agent of peroxynitrite. Activation
of the TGF-β pathway, which regulates different cell processes and functions, including
cell proliferation and apoptosis, has been demonstrated in several pathological conditions,
such as chronic kidney disease (182). TGF-β mesangial extracellular matrix deposit is the
most common component in fibrogenesis scheme. More recently, our team showed that
NADPH oxidase-mediated miR21 activation significantly upregulated TGF-β protein level
in the condition of NAFLD (74). The result showed that miR21 inhibited SMAD-7 and
PTEN, which target the SMAD2/3 pathway, is a critical step in TGF-β activation. In this
study, we affirm this model of the microcystin activated TGF-β signaling pathway.
NAFLD mice treated with microcystin-LR showed high immunoreactivity of TGF-β
compared with the NAFLD group (fig.9. A and B) which suggest that chronic exposure to
microcystin activates the TGF-β pathway and produces the extracellular matrix which is a
vital sign of fibrosis. On the other hand, miR21 KO mice showed less TGF-β
immunoreactivity, which means the activation of TGF-β pathway is miR21 dependent.
Furthermore, PTEN protein levels were attenuated in mice exposed to microcystin, in
parallel, mice with specific genes knocked out like P47phox and miR21 had a significant
increase in PTEN protein level (fig. 10. A and B). The results above prove the existence of
microcystin activated NOX2- miR21 axis, which attenuates PTEN expression resulting in
the TGF-β signaling pathway.
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Taken together, our data describe a novel mechanistic role of microcystin-LR in
augmenting NAFLD caused nephrotoxicity via NOX2- miR21 axis in mesangial cells
resulting in the release of TGF-β and tubular inflammation. Our results will help advance
the current knowledge of the microcystin-LR mechanism and show the targeting of NOX2
by use apocynin, suggexting that apocynin might be a candidate for an interventional
strategy to reduce ectopic inflammatory events in NAFLD with microcystin exposure.
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Figure 4. 1 Microcystin increases immune cell filtration in glomerulus:Microcystin-LR
exposure heightened HAFLD causes immune cells infiltration in glomeruli and damage the
glomerular structure. hematoxylin and eosin-stained paraffin-embedded kidney tissue
sections (Lean+ MC; i) mice fed with normal chow diet and treated with microcystin-LR,
(NAFLD; ii) mice were kept on MCD diet without microcystin treatment, and
(NAFLD+MC; iii) NAFLD mice treated with microcystin-LR. Images were taken at 60X.
(*P<0.05).

Figure 4.2 Microcystin exposure augment mesangial cell activation in NAFLD condition
A, Immunoreactivity of alpha smooth muscle actin (α-SMA, a marker for mesangial cell
activation) as shown by immunofluorescent in kidney slices from mice fed with MCD diet
(NAFLD) serve as a control, NAFLD mice exposed to microcystin-LR (NAFLD+MC),
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microcystin administration to lean mice (lean+ MC), Images were taken at 20X. B,
Morphometric analysis of α- SMA immunoreactivity (mean data measured as arbitrary
light units from three separate microscopic fields were plotted on y-axis) in NAFLD,
NAFLD+MC, and lean+MC groups (*P<0.05).

Figure 4.3 Microcystin exposure heighten glomerular inflammation in NAFLD exist.
mRNA expression analysis of IL-1β, MCP-1, CD68, and F4/80 genes in kidney tissue of
lean+MC, NAFLD, and NAFLD+MC. A, mRNA expressions of IL-1β. B, mRNA
expressions of MCP-1. C, mRNA expressions of CD68. D, mRNA expressions of F4/80.
All mRNA expression had been assessed by quantitative real-time PCR (qRTPCR) and
expressions were normalized against NAFLD group (*P<0.05).
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Figure 4.4 Microcystin exposure activate mesangial cell NOX2 Microcystin-LR activated
NADPH oxidase (NOX2) via transported cytosolic subunit (P47phox) to membrane and
colocalized with membranal subunit (GP91phox) A, Immunofluorescence for P47Phox
(Green) and GP-91 Phox (Red) co-localization (Yellow)in kidney slices from mice fed
MCD diet (NAFLD), NAFLD mice exposed to microcystin-LR (NAFLD+MC), and
P47phox gene deficient mice fed with MCD diet and exposed to microcystin-LR (P47phox
KO +MC). B, Morphometric analysis of GP91/P47phox colocalized in NAFLD,
NAFLD+MC, P47phox KO+MC group of mice. All immunofluorescent Images were
taken at 20X and mean colocalize measured as arbitrary light units from three separate
microscopic fields were plotted on y-axis) (*P<0.05).
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Figure 4.5 Microcystin mediates mesangial cell NOX2 generated peroxynitrite:
Microcystin-LR generates peroxynitrite via NADPH oxidase (NOX2). A,
Immunofluorescence for 3-Nitro-tyrosine (Red) reactivity in Kidney tissue from mice fed
MCD diet (NAFLD), NAFLD mice exposed to microcystin-LR (NAFLD+MC), and
P47phox gene deficient mice fed with MCD diet and exposed to microcystin-LR (P47phox
KO + BDCM) images were taken in 20X. B, Morphometric analysis of GP91/P47phox
colocalized in NAFLD, NAFLD+MC, P47phox KO+MC group of mice. All
immunofluorescent Images were taken at 40X and mean colocalize measured as arbitrary
light units from three separate microscopic fields were plotted on y-axis) (*P<0.05).C,
Immunoreactivity of (α- SMA) as shown by immunofluorescent in kidney slices from
(NAFLD) serve as a control, NAFLD+MC, and P47phox KO+ MC, Images were taken at
60X. D, Morphometric analysis of α- SMA immunoreactivity (mean data from three
separate microscopic fields were plotted on Y-axis0 in NAFLD, NAFLD+MC and
P47phox KO groups of mice (*P<0.05).
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Figure 4.6 Microcystin administration upregulates Mesangial cell
miR21expression.
Microcystin-LR-induced NADPH oxidase activation mediates upregulation of micro-RNA
21 (miR21). qRT-PCR analysis of miR21 expression of Mesangial cell (control),
mesangial cell incubated with leptin and treated with microcystin (MC+MC+leptin),
mesangial incubated with leptin and treated with both microcystin and apocynin
(MC+Apo+leptin), and mesangial incubated with leptin and treated with both microcystin
and FBA (MC+FBA+leptin). (*P < 0.05).
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Figure 4.7 miR21 high expression causes mesangial cell activation: α-SMA
immunoreactivity as shown by immunofluorescent in kidney slices from NAFLD mice
served as a control, NAFLD mice treated with microcystin-LR (NAFLD+MC), and
miRNA-21 mice fed with MCD diet and exposed to microcystin (miR21 KO+MC), Images
were taken at 20X. B, morphometric analysis of α- SMA immunoreactivity (mean data
from three separate microscopic fields were plotted on Y-axis0 in NAFLD, NAFLD+MC
and miR21 KO groups of mice. C, immunoreactivity of α-SMA as shown by
immunofluorescent in mesangial cells (control), mesangial cells exposed to both leptin and
microcystin-LR (Leptin+MC), and cells treated leptin and microcystin-LR plus apocynin
(leptin+MC+Apo), FBA (leptin+MC+ FBA), or miR21 inhibitor (leptin+MC+miR21 inh.),
Images were taken at 40X. D, morphometric analysis of α- SMA immunoreactivity (mean
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data from three separate microscopic fields were plotted on Y-axis0 in cell control,
leptin+MC, leptin+MC+Apo, leptin+MC+FBA, and leptin+MC+miR21 inh. (*P < 0.05).

Figure 4.8 Peroxynitrite- miR21 axis drives mesangial cell activation and death:
Microcystin-induced NOX2 generate peroxynitrite and mir21 activation activates increase
mesangial cell activation and death. A, immunoreactivity of 3NT as shown by
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immunofluorescent in mesangial cells (control), mesangial cells exposed to both leptin and
microcystin-LR (Leptin+MC), and cells treated leptin and microcystin-LR plus apocynin
(leptin+MC+Apo), FBA ( leptin+MC+ FBA), or miR21 inhibitor (leptin+MC+miR21
inh.), Images were taken at 20X. B, morphometric analysis of 3NT immunoreactivity
(mean data from three separate microscopic fields were plotted on Y-axis0 in cell control,
leptin+MC, leptin+MC+Apo, leptin+MC+FBA, and leptin+MC+miR21 inh. (*P < 0.05).
C, mumber of apoptotic nuclei as shown by TUNEL immunofluorescence staining in
leptin+MC, leptin+MC+Apo, leptin+MC+FBA, and leptin+MC+miR21 inh. The number
of TUNEL-positive cells identified by their green-stained images were taken at 40X. D,
percentage of TUNEL-positive cells (obtained by morphometric analysis done on images
from three separate microscopic fields) in cell control, leptin+MC, leptin+MC+Apo,
leptin+MC+FBA, and leptin+MC+miR21 inh. (*P < 0.05).
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Figure 4.9 miR21 activates mesangial cell toxicity via increasing TGF-β: A,
immunoreactivity of transforming growth factor (TGF)-β, as shown by
immunohistochemistry in kidney slices from lean+MC (i), NAFLD (ii), NAFLD+MC (iii)
and miR21 KO + MC (iv) groups of mice. All images were taken at 60X. B, morphometric
analysis of TGF- β immunoreactivity (obtained by morphometric analysis done on images
from three separate microscopic fields) in the lean+MC (i), NAFLD (ii), NAFLD+MC (iii)
and miR21 KO + MC (iv) groups. *P < 0.05.

Figure 4.10 NOX2- miR21 axis heightens mesangial cells activation via PTEN
decreasing:A, Western blot analysis of PTEN protein levels followed by normalizations
against β-actin in lean+MC, NAFLD, NAFLD+MC, and miR21 KO + MC, and
P47phox+MC groups. B, morphometric analysis of PTEN/ β-Actin ratio.
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CHAPTER 5
CONCLUSION
Obesity has become a public health problem. The prevalence of obesity has doubled in
adults and children in the last two decades. Two thirds of Americans are overweight or
obese. Obesity is a multifaceted disorder which reduces quality of life and dramatically
increases of developing various physical diseases, which are the leading causes of death
not only in the U.S. but also worldwide. Although genetic factors can contribute to the
development of obesity, individual and societal behaviors, like education, food market,
eating patterns, and physical activity are also important factor in increase obesity rates.
People who have obesity are predisposed to have other diseases and health conditions,
including, diabetes, heart disease, stroke, nonalcoholic fatty liver disease and some types
of cancer. NAFLD, which is an umbrella term for numerous stages of disease, is a hepatic
manifestation of metabolic syndrome which emerges due to abnormal fat (<5% of the liver
weight) accumulation in the liver. The most acceptable theory for progressing nonalcoholic
steatohepatitis (NASH), an advance stage of NAFLD, is a multi-hits theory. Accumulation
of fat presents the first hit, which increases the vulnerability of the liver to various second
hits, including oxidative stress, proinflamatory cytokines, adipokines and mitochondrial
dysfunction that lead to fibrosis and cellular death and sometimes lead to hepatic cancer.
Several studies in mice and human models showed that environmental toxins like
environmental pollution including air, soil, and water pollutants, as well as chemical
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materials could be considered risk factors for the onset of NAFLD and could increase the
progression of NASH. Previous studies from our group have shown that chronic exposure
to low doses of Bromo-dichloromethane (BDCM), a disinfectant byproduct when chlorine
is used to control microbial contaminants in human water resources, is able to exacerbate
liver injury causing Non-alcoholic steatohepatitis (NASH) where CYP2E1 mediated
oxidative stress acts as the secondary hit in obese mice. Indeed, several studies link
NAFLD with extrahepatic disorders, in the present study, I examined the molecular
mechanisms by which the kidney is affected by an underlying condition of NASH induced
by BDCM exposure. I also studied the role of microcystin-LR, a cyanobacteria
heptapeptide toxin in the exacerbation of NAFLD caused kidney damage.
In the last two decades, several studies have focused on the communication and
linkages between NAFLD and chronic kidney disease (CKD) (31,152), however the exact
mechanism of the process is largely unclear. Here, I investigated the role of cytochrome
P450 (CYP2E1) mediated NAFLD caused kidney immunotoxicity. High-fat (60% kcal)
diet-fed BDCM induced mouse NASH models were used for this study along with mice
deficient in genes for CD1D gene, PFP/Rag2 dual gene, and TLR4 gene deletion to show
the molecular mechanistic role of different cells including NK and NKT cell in kidney
inflammation. Mesangial cells and tubular cells were also used in this study in order to
prove the function of these cells in our model. Our result showed that NAFLD mice
produced BDCM, a CYP2E1 substrate, mediated lipid peroxidation in tubular cell. Lipid
peroxidation increased proinflammatory markers like IL-1β, TNF-α, and IFN-γ as well as
mesangial cell activation, as indicated by the immunoreactivity of α-SMA, a marker of
mesangial cell proliferation. The increase in the expression of inflammatory markers was
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remarkable lower in mice were treated with BDCM plus diallyl sulfate (DAS) a CYP2E1
blocker while all proinflammatory cytokines that were used in this study were highly
expressed in mice that lack the CD1d gene. This indicate that CYP2E1 response to
mesangial cell activation while NKT cells play a dynamic protective role in kidneys
exposed to BDCM. In- vitro, mesangial cells were incubated with 4HNE, a lipid
peroxidation marker. α-SMA and TGF-β expression was higher in mesangial cells treated
with 4HNE compared with control cells. Then, tubular cells were treated with the
mesangial cell supernatant. The results showed that tubular cells had significant
immunoreactivity after being treated with mesangial cell supernatant, which suggests that
mesangial cells play a key role in renal toxicity.
Leptin, a small peptide hormone mainly produce by adipocyte, has a direct effect
on various cell types in the glomerulus including mesangial cells. In turn this leads to the
release of proinflammatory cytokines, such as IL-1β and TGF-β I and II (183, 184).
Previous studies from our group showed that mice fed high fat diet and exposed to BDCM
had increase leptin concentration which in turn led to NADPH oxidase (NOX2) activation
and miR21 upregulation as a key regulator of fibrogenesis in the NASH (100, 119, 137).
Here, I explored the role of leptin in renal toxicity in the condition of NAFLD. Wildtype
mice fed a high fat diet (60% Kcal), along with mice with specific gene knock outs, like
leptin KO, P47phox KO, and miR21 KO were used in this study. The results showed that
the NAFDL group treated with BDCM had a significant increase in α-SMA
immunoreactivity as well as high levels of proinflammatory cytokine release. The
glomerular immunoreactivity and tubular inflammation were decreased in the leptin KO
and P47phox KO mice. NOX2 activation resulted in the release of free radicals and
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Peroxynitrite generation (185), however, the role of peroxynitrite generation in ectopic
glomerulonephritis is unclear. Here, I studied how peroxynitrite leads to renal damage. My
results showed that NAFLD mice had a dramatic increase in tyrosine nitration, as assessed
3 nitro tyrosine immunoreactivity. Leptin KO and P47phox KO had a significant decrease
in tyrosine nitration.

Furthermore, miR21 KO mice showed significant decrease in

proinflammatory mediators, suggesting that high circulatory leptin in NAFLD causes renal
mesangial cell activation and tubular inflammation via a NOX2 dependent pathway that
upregulates proinflammatory miR21. In-vitro, I used mesangial cells to explore this
mechanistic pathway. Mesangial cells that were treated with leptin showed high
immunoreactivity of α-SMA while using apocynin or phenyl boronic acid (FBA) or DMPO
or miR21 antagomir inhibited leptin induced-miR21-mediated mesangial cell activation invitro. This suggested the direct role of leptin-mediated NOX-2 in miR21-mediated
mesangial cell activation. In addition, I showed that JAK-STAT inhibitor totally revoked
the mesangial cell activation in leptin-primed cells, suggesting that leptin signaling in the
mesangial cells depends on the JAK-STAT pathway.
The contamination of natural water resources by cyanotoxins produced by
cyanobacterial blooms is a worldwide problem, causing serious water pollution to humans
and livestock. Although the toxicity of microcystin-LR, a most potent cyanotoxin,
primarily targets the liver, other organs can be targeted too, including the kidney (186)
however the role of microcystin-LR in renal inflammation in NAFLD condition in not
totally

understood.

Here,

I

investigated

the

microcystin

mediated

ectopic

glomerulonephritis via NOX2- miR21 axis. Wildtype mice as well as mice that with
disrupted P47phox gene and miR21 gene were used in this study. NAFLD mice treated
108

with microcystin-LR (10µg/Kg) showed increased α-SMA marker as well as other
proinflammatory cytokines, such as IL1β, MCP-1, CD68, and F4/80. NOX2 was also
activated, as indicated by colocalization of NOX2 subunits (P47phox and GP91phox).
Remarkably, the colocalization events along with tyrosine nitrations were decreased in
P47phox KO mice suggesting that microcystin impacts NAFLD kidney through mesangial
cell NOX2 activation. Since the TGF-β signaling pathway is controlled by miR21attenuated PETN and SMAD7, I looked for PTEN activity and I found that PTEN levels
were significantly decreased in NAFLD mice treated with microcystin. miR21 KO mice
had a remarkable increase in PTEN levels. TGF-β signaling pathway also showed increased
immunoreactivity in NAFLD+ microcystin group with less activation in miR21 KO mice.
These results suggested that microcystin toxicity associated with kidney disruption occurs
via mesangial cell NOX2 activation and miR21 upregulation. To investigate microcystin’s
role in apoptosis, mesangial cells were treated with microcystin-LR. The results showed
that microcystin increased the number of apoptotic cells while this number decreased in
cells incubated with apocynin or phenyl boronic acid (FBA) or miR21 antagomir
suggesting that microcystin causes mesangial cell apoptosis via NOX2- miR21 axis. This
thesis emphasizes that environmental toxins can damage the kidney and demonstrates the
ectopic manifestation of NAFLD. Increased public consciousness about obesity and
NAFLD, as well as encouraging people to adopt health eating and active lifestyles can help
in reducing the mortality of NAFLD and slow its progression.
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